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Iron deficiency is the most common nutritional deficiency worldwide. Whole body
iron balance is primarily controlled through the regulation of intestinal iron absorption.
Therefore, the identification of factors that affect iron absorption is important for the
development of therapies aimed at improving iron status in deficient individuals. We
recently found that increasing dietary protein in rats enhances duodenal iron absorption.
This protein-induced increase in iron absorption is associated with augmented transcript
levels of key intestinal iron transporters, including the iron importer, DMT1.
To determine whether dietary protein directly affects DMT1 expression in vitro,
the effect of amino acid supplementation on DMT1 transcript expression and promoter
activity was evaluated in Caco-2 cells. Amino acids significantly augmented DMT1
transcript expression by 1.8-fold (P = 0.004) and DMT1 promoter activity by 1.6-fold (P
< 0.0001) compared to control cells.
Since hepcidin is a major regulator of iron absorption and iron transporter
expression, the impact of increasing dietary protein/amino acids on hepatic hepcidin
expression was evaluated in vivo in rats and in vitro in primary rat hepatocytes. In rats
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consuming a high protein diet, hepatic hepcidin expression was suppressed by 44%
compared to those on a medium protein diet (P = 0.0006). There was no direct effect of
amino acids on hepcidin transcript expression in primary hepatocytes.
Finally, to determine whether the effect of dietary protein on iron absorption is
relevant to humans, iron status of postmenopausal women who recently completed a
double-blind placebo controlled dietary protein supplementation trial was examined.
Acutely increasing dietary protein had no significant effect on serum iron status
parameters including serum ferritin, hepcidin, and % transferrin saturation.
In conclusion, increasing dietary protein in the short-term in rats significantly
enhances intestinal iron absorption, which is due at least in part to enhanced duodenal
DMT1 transcription and reduced hepatic hepcidin expression. However, acutely
increasing protein intake has no significant impact on iron status in iron-replete
postmenopausal women. Future work is needed to determine the mechanisms by
which increasing dietary protein/amino acids affect duodenal DMT1 transcription and
hepatic hepcidin expression and its relevance to the treatment of iron deficiency in
humans.
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Chapter 1
Introduction

The central hypothesis of this work is that dietary protein regulates the
expression of genes vital to iron absorption and metabolism. In particular, this thesis
focuses on the effect of increasing dietary protein on the expression of DMT1, a
critically important enterocyte iron importer, and hepcidin, the principal regulator of iron
absorption.
Chapter 2 is a review article that provides an overview of the physiology of iron
metabolism. Particular attention is given to the molecular pathways central to iron
absorption as well as the regulatory mechanisms controlling iron absorption and
metabolism.
Chapter 3 reviews our current understanding of nutrient effects on intestinal iron
absorption with a focus on dietary protein. This article summarizes both early and
recent literature examining the relationships between dietary factors and iron
bioavailability and absorption. Underlying molecular mechanisms that may explain
these effects are also discussed.
Chapter 4 details the preliminary data that led to the present work, which adds to
the growing literature addressing whether dietary protein affects intestinal iron
absorption. This study, recently published in Faseb J, demonstrates that increasing
dietary protein in rats significantly augments iron absorption and the expression of
duodenal iron transporters.
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Chapter 5 is new work that examines the impact of a short-term high protein diet
on iron status in humans. Overall, no statistically significant association between
increasing dietary protein and iron status was observed.
The experiments described in Chapter 6 were designed to determine whether
amino acids directly affect duodenal DMT1 expression. Exposing Caco-2 cells to amino
acids significantly augmented DMT1 mRNA levels, due at least in part to an effect on
gene transcription.
The in vivo and in vitro experiments presented in Chapter 7 sought to determine
if dietary protein/amino acids impact hepatic hepcidin expression. In rats, increasing
protein intake from a medium to a high level significantly suppressed hepcidin mRNA
expression. Interestingly, this was associated with alterations in expression of genes
involved in the regulation of hepcidin transcription. However, there was no direct effect
of amino acids on hepcidin expression in primary rat hepatocytes.
Chapter 8 summarizes the experiments detailed in Chapters 5, 6, and 7, and
provides possible direction for future research.
Chapter 9 discusses the significance and public health implications of the current
work.
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Chapter 2
The Physiology of Iron Absorption & Metabolism
Introduction
Iron is a trace mineral essential for a variety of biological processes. It functions
as a key component of hemoglobin, myoglobin, cytochromes, and countless enzymes.
Iron exists in several oxidation states, the principal ones being ferrous (Fe2+) and ferric
(Fe3+), and has the ability to form bonds with electronegative elements such as oxygen,
nitrogen, and sulfur.1 Consequently, iron has wide-ranging physiologic roles. As an
example, the enzyme aconitase, which contains an iron-sulfur cluster, plays an
important role in the tricarboxylic acid cycle, a series of chemical reactions used to
generate energy from carbohydrates, fats and proteins.2 Heme, which is a component
of the metalloproteins hemoglobin and myoglobin, is another vital iron-containing
compound that consists of an iron ion held in a porphyrin ring. The iron within the heme
moiety of hemoglobin binds and transports oxygen in erythrocytes, while the heme iron
of myoglobin carries oxygen in muscle.2 Although iron plays a critically important role in
a multitude of cellular processes, in excess it is potentially toxic and may cause
significant organ damage through the generation of reactive oxygen species.3
Therefore, the maintenance of iron balance is important for ensuring the availability of
sufficient iron for crucial biological processes but also for the prevention of iron toxicity
and iron-induced oxidative stress. The purpose of this chapter is to review the
pathways involved in iron absorption and metabolism and to describe the major
regulatory mechanisms that control these processes.
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Iron homeostasis
Iron homeostasis, or the maintenance of iron stores and extracellular iron
concentrations, is mainly accomplished through the regulation of dietary iron absorption
and iron release from storage pools. Extracellular iron concentrations are largely
dependent on the latter, while whole body iron balance is achieved through alterations
in intestinal iron absorption.
Dietary iron is primarily absorbed in the proximal small intestine, where ~1-2 mg,
or roughly 10% of the iron that passes through the GI tract daily, is taken up by
duodenal enterocytes.4 This absorption is balanced by loss of a similar amount of iron
through blood loss and the sloughing of skin and mucosal cells. Once dietary iron is
absorbed, it is transferred to the circulation and bound to transferrin, which transports it
to tissues for storage or utilization. Total body iron ranges between 3-5 g. The majority
is found in the erythroid bone marrow and in hemoglobin mature erythrocytes contained
within the heme of hemoglobin. Iron used for erythropoiesis is predominantly supplied
by reticuloendothelial macrophages, which store and recycle iron from senescent red
blood cells (RBCs). From 0.5-1 g of total body iron is stored in hepatocytes.5
Dietary iron absorption is influenced by body iron requirements. For example,
states of iron deficiency and excess enhance and reduce duodenal iron uptake,
respectively.6 In iron deficiency, absorption is augmented to 2-4 mg and in iron
overload it is reduced to 0.5 mg.7 Additionally, erythropoietic drive has been shown to
augment intestinal iron absorption in order to provide adequate iron for new RBC
synthesis.8
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A particularly striking example of a situation in which iron absorption is altered in
response to increasing iron needs is pregnancy. In the 3rd trimester of gestation, iron
requirements increase to ~7-10 mg/d compared to 1 mg/d in the beginning of the 2nd
trimester in an effort to sustain the increase in RBC mass and fetal growth that occur at
this time.9 To compensate for the dramatic rise in iron requirements and maternal-fetal
iron transfer that occurs in late pregnancy, maternal iron absorption is concomitantly
enhanced in the 2nd and 3rd trimesters.9
While the absorption of iron can be modified in response to changing
requirements, there is no efficient physiologically regulated excretion mechanism for
iron. For this reason, the regulation of intestinal iron absorption is critical for maintaining
appropriate iron balance and for optimizing iron status.

Enterocyte iron absorption
Dietary iron exists in two forms: heme iron and nonheme iron. Nonheme iron, or
inorganic iron, represents the majority (~⅔) of the iron that humans consume.10
Nonheme iron is present in vegetables and meat, while heme iron, derived from
hemoglobin and myoglobin, is found exclusively in animal meat and is more bioavailable
than nonheme iron. Both heme and nonheme iron are absorbed by duodenal
enterocytes, however, the degree to which they share similar pathways and transport
proteins in this process, and whether the same regulatory mechanisms are in place to
control their export, is largely unknown.
The mechanism of intestinal nonheme iron absorption has been well
characterized and involves the coordinated action of several enterocyte iron
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transporters. Duodenal nonheme iron uptake begins with the reduction of Fe3+ to Fe2+
at the apical membrane of enterocytes by the brush border ferrireductase, duodenal
cytochrome b (Dcytb).11 Once in the ferrous form, the iron is imported into the cell by
the apical transmembrane iron transporter, divalent metal transporter 1 (DMT1).12,13 In
the enterocyte, the absorbed iron can be stored in the cell as ferritin, used for various
cellular processes, or exported into the circulation by the basolateral iron exporter,
ferroportin 1 (FPN1).14 However, at this time the process by which inorganic iron is
transported through the enterocyte is unknown. Metallochaperones are known to exist
for many minerals but a specific iron trafficking protein remains uncharacterized. In
order for iron to bind to apo-transferrin in the circulation, the iron must be re-oxidized
from the Fe2+ to the Fe3+ form, which is accomplished by the basolateral membranebound enterocyte ferroxidase, hephaestin (HEPH), or the circulating ferroxidase,
ceruloplasmin (CP).15 In the bloodstream, transferrin, which can bind up to two iron
ions, transports iron to tissues expressing the transferrin receptor (TfR), which take up
the transferrin-iron complex via receptor-mediated endocytosis.16 In the endosome, iron
is released from transferrin and TfR by acidification. The free iron is then transported
across the endosomal membrane by DMT1, and is either utilized by the cell for the
synthesis of iron-containing proteins, or stored in ferritin.
Although heme iron absorption has been studied for decades, its absorption
pathway is less well understood than that of nonheme iron. In 2008, West and Oates
summarized the current hypotheses and controversies regarding heme iron absorption
and described two predominant hypotheses in detail.10 The first postulates that heme is
taken up by the enterocyte via receptor-mediated endocytosis and is catabolized within
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the cell in internalized vesicles. Following catabolism, the heme-derived inorganic iron
may then join the labile iron pool and undergo similar fates as absorbed nonheme iron
(i.e., storage in ferritin, utilization by the cell, or efflux into the circulation via FPN1).
This hypothesis is supported by two separate studies, which both utilized mammalian
closed duodenal loops.17,18 In these experiments, the investigators instilled heme or
hemoglobin in the intestinal loops, and evaluated the appearance of heme in the
duodenal mucosa over time. Both studies showed initial heme localization at the
microvillous membrane, followed by its presence within tubulovesicular structures in the
apical cytoplasm, and finally in secondary lysosomes.
The second hypothesis suggests that heme iron is transported into and through
the enterocyte intact by membrane-bound heme import and export proteins. In this
model, heme iron is first imported into the cell by a brush border membrane heme
importer, the proton-coupled folate transporter/heme carrier protein 1 (PCFT/HCP1),
then is transported through the cell intact and exported into the circulation by a
basolateral membrane export protein, feline leukemia virus subgroup C receptor-related
protein (FLVCR). If exported into the circulation intact through FLVCR, the heme would
most likely be transported throughout the bloodstream bound to hemopexin (HPX),
which helps prevent heme-mediated oxidative stress and heme-bound iron loss.19
Alternatively, the heme moiety may be degraded within the enterocyte by the enzyme
heme oxygenase 1 (HO-1), which would produce inorganic iron, carbon monoxide (CO),
and biliverdin IXα. The free iron released from heme as a result of this catabolic reaction
would then join the cytoplasmic nonheme iron pool and either be stored, utilized by the
cell, or exported via FPN1.
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While these two different models of heme absorption mechanisms are plausible,
neither has been completely validated and important questions remain unanswered.
For example, although PCFT/HCP1 was first identified as a heme iron transporter, it is
now known that it has a higher affinity for folate, suggesting that folate is its primary
substrate.20,21 Additionally, while FLVCR has been shown to export heme iron in other
tissues and is highly expressed in Caco-2 cells, FLVCR-mediated heme export in the
intestine has not been demonstrated.
A recent study from the Insogna and O’Brien laboratories sought to elucidate the
mechanisms by which heme iron is absorbed, and to gain insight into whether
PCFT/HCP1 and FLVCR1 are involved.22 In this study, the effect of iron loading on
intestinal heme iron absorption and the expression of duodenal heme transporters in
rats was investigated. It is known that iron loading significantly reduces enterocyte
nonheme iron absorption, in part by reducing basolateral expression levels of FPN1 and
apical expression of DMT1 and Dcytb. However, it is not clear whether increasing
circulating iron concentrations similarly regulate heme iron uptake. Interestingly, in this
study, iron overload suppressed heme iron absorption by 80% compared to controls,
which was similar to the reduction observed in nonheme iron absorption. However, this
drop in heme absorption could not be explained by changes in the expression levels of
PCFT/HCP1 or FLVCR1, as these transporters were not altered in response to iron
loading at either the transcript or protein level compared to controls. The considerable
reduction in heme iron absorption was however associated with significant decreases in
both DMT1 and Dcytb mRNA expression (r= 0.8 and r= 0.9, respectively; P < 0.01 for
both), and modest non-significant reductions in FPN1 and HEPH. Thus, these data
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may support the hypothesis that heme, if transported into the enterocyte intact, is
catabolized within the cell and joins the nonheme iron pool before being exported into
the circulation. On the other hand, it is possible that iron loading reduces heme
absorption not by affecting expression levels of PCFT/HCP1 and FLVCR1, but by
causing the translocation of these transporters from the cell membrane to the
cytoplasm. Finally, these findings could point to the existence of as yet unidentified
apical and basolateral heme transporters that are responsive to increasing circulating
iron concentrations.
Therefore, while progress has been made and potential heme transporters are
beginning to be characterized, the elucidation of a cohesive heme iron absorption
mechanism is still incomplete and warrants further investigation.

Regulation of iron absorption and metabolism by hepcidin
As mentioned previously, excess body iron is potentially toxic and can lead to
oxidative stress and tissue damage. The lack of an efficient iron excretion mechanism
makes the regulation of intestinal iron absorption of paramount importance for
maintaining iron balance and preventing iron overload. The extent to which iron is
absorbed in the intestine is largely controlled by the recently identified iron-regulatory
hormone, hepcidin. Hepcidin is an antimicrobial peptide hormone produced in the liver
as an 84-amino acid propeptide, which is cleaved to a 25-residue peptide before
secretion into the bloodstream.23 Hepcidin transcription is induced in response to iron
overload and inflammation, and is suppressed by hypoxia, erythropoiesis, and iron
deficiency.24-27 Hepcidin directly reduces duodenal nonheme iron absorption by binding

9

to FPN1 on the basolateral membrane of enterocytes, which results in hepcidin-FPN1
complex internalization and degradation.28 This causes inhibition of iron efflux from the
enterocyte into the blood and ultimately reduces apical iron uptake.29 The reduction in
brush border iron absorption as a result of hepcidin action on FPN1 may be caused by:
1) cellular iron accumulation, which may inactivate iron regulatory proteins (IRPs) and
subsequently destabilize DMT1 mRNA; 2) hypoxia-inducible factor-2α (HIF-2α)
degradation, which could reduce DMT1 transcription; and/or 3) ubiquitin ligase
activation triggered by the binding of hepcidin to ferroportin, which may in turn induce
proteasomal degradation of DMT1 and/or other apical membrane transporters.30-32
Regardless of the mechanism, the ultimate result of increased hepatic hepcidin
production and secretion is suppression of duodenal iron absorption.
While the hepcidin-induced reduction in iron absorption described above is
known to occur for nonheme iron, whether hepcidin plays a key regulatory role in heme
iron absorption is less clear. However, if the hypothesis that heme iron is catabolized
within the enterocyte before being exported is correct, it is reasonable that hepcidin also
affects enterocyte heme iron uptake. And in fact, in the previously mentioned study by
the O’Brien group, iron overloaded rats exhibited an 80% reduction in intestinal heme
iron absorption, which was significantly inversely associated with hepatic hepcidin
mRNA expression (r = -0.77, P = 0.003), suggesting that hepcidin may indeed also
negatively regulate duodenal heme iron uptake. To our knowledge, this is the first in
vivo study demonstrating a potential regulatory role of hepcidin on both nonheme and
heme iron absorption.
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Besides attenuating intestinal iron absorption, hepcidin also impacts the recycling
of iron from senescent RBCs by reticuloendothelial macrophages and the release of
iron from stores in hepatocytes. Similar to duodenal enterocytes, macrophages and
hepatocytes express the iron exporter FPN1 on their cell surface, which is responsible
for iron flux out of the cell and into the circulation. To block macrophage/hepatocyte
iron release, hepcidin binds to and causes the internalization and degradation of FPN1,
effectively sequestering iron in the cell.33 The end result is a reduction in circulating iron
concentrations.
The importance of hepcidin in maintaining optimal iron balance can be
appreciated when considering hereditary hemochromatosis (HH), a common autosomal
recessive disorder that causes iron overload. The estimated prevalence of HH in the
United States is between 1 and 200 and 1 in 500 and primarily affects individuals of
northern European descent.34 Serious complications of uncontrolled HH include
cirrhosis, diabetes, cardiomyopathy, hypogonadism, and death.35 When diagnosed
early, HH can be managed and HH-related organ failure prevented by periodic
phlebotomy.36 There are several forms of HH but most are caused by two missense
mutations in the hemochromatosis gene HFE, C282Y and H63D leading to loss of
function. An estimated 50% to 100% of HH cases are individuals homozygous for the
C282Y mutation.37 These mutations in HFE cause a significant attenuation in hepcidin
production leading to inappropriate absorption of dietary iron and liver iron overload.38
While heterozygosity for the C282Y mutation is often associated with increased levels of
transferrin saturation and serum ferritin, it is rarely associated with liver damage.37 That
being said, individuals with an HFE mutation on a single allele may be at increased risk
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for other serious diseases. For example, Shaheen et al. demonstrated that subjects
with any HFE gene mutation are significantly more likely to have colon cancer than
subjects with no HFE mutation (adjusted OR = 1.40, 95% CI = 1.07 to 1.87).39 Similarly,
the frequency of at least one C282Y allele in breast cancers was higher than
frequencies in the general population (36.6% vs. 17%, respectively; P = 0.008).40 The
authors suggest that heterozygosity for an HFE gene mutation might predispose
individuals to cancer due to chronic subclinical increases in total body iron stores, which
in turn may promote increased oxidative stress and DNA damage.
These are just a few examples of the many consequences of hepcidin
inadequacy that underscore its importance in the regulation of systemic iron
homeostasis and the prevention of iron toxicity.

Regulation of iron absorption and metabolism by other factors
Although hepcidin is viewed as the most important systemic regulator of iron
absorption and metabolism, there are local mechanisms that provide additional
protection from cellular iron deficiency and toxicity. One of these is the Iron Responsive
Element/Iron Regulatory Protein (IRE/IRP) system. The IRE/IRP system helps to
control iron absorption and metabolism through posttranscriptional regulation of key
iron-related genes in response to iron availability. IREs are stem loop structural motifs
consisting of ~30 nucleotides that are located in the untranslated regions (UTRs) of the
mRNAs for genes involved in iron transport and storage, including DMT1, ferritin, FPN1,
and TfR1.41 Regulation of gene expression/protein translation is achieved by the
binding of IRPs to the IRE of a transcript. In some cases, IRP activation and binding
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inhibits translation, while in other cases it enhances mRNA stability. The location of the
IRE of a particular gene is generally indicative of its function. For example, when IREs
are found in the 5’ UTR, IRP binding induced by iron deficiency blocks translation. In
times of iron sufficiency, IRPs assemble an iron-sulfur cluster and are rendered inactive
and incapable of binding to the 5’ IREs, allowing translation to proceed. Conversely,
when IREs are present in the 3’ UTR, IRP binding as a result of iron scarcity stabilizes
mRNA expression, while iron repletion or overload causes transcript degradation.
Ferritin, FPN1, and HIF-2α have IREs in their 5’ UTRs, while DMT1 and TfR1 have IREs
in their 3’ UTRs.42 Therefore, in iron-starved cells, IRPs are active, TfR1 and DMT1
mRNAs are stabilized, and ferritin translation is inhibited. This allows iron deficient cells
to increase their ability to take up transferrin-bound iron and minimize its sequestration
into ferritin.
Oxygen deprivation (hypoxia) has also been found to impact iron metabolism and
the expression of iron-related genes. The regulation of gene expression in response to
hypoxia is accomplished by a family of oxygen-related heterodimeric transcription
factors known as hypoxia-inducible factors (HIFs). Three HIFs have been characterized
thus far: HIF-1α, HIF-2α, and HIF-3α.43 In normoxia, the HIF regulatory α subunits are
hydroxylated by prolyl hydroxylases (PHDs) and subsequently degraded through the
ubiquitin-proteasome pathway.44 However, under hypoxic conditions or iron depletion,
PHDs are inhibited, resulting in stabilization of the HIF regulatory subunit, which can
then heterodimerize, translocate to the nucleus, and trans-activate HIF target genes.
HIFs alter transcription of their targets by binding to hypoxia-responsive elements
(HREs) located in their promoter regions. Several iron-related genes possess HREs,
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including hepcidin, DMT1, and erythropoietin (EPO). As an example, HIF-1α binding to
the hepcidin HRE causes repression of hepcidin transcription, which may ultimately
serve to increase cellular iron export and availability for erythropoiesis.45 At the same
time, stabilization and binding of HIF-2α to HREs in the DMT1 promoter induces DMT1
transcription and intestinal iron absorption.44
Therefore, even though hepcidin is a crucial regulator of iron homeostasis, other
safeguards are in place to further protect the body from iron deficiency and excess.

Summary
Iron is a mineral that is unique in a number of ways. Although indispensible, iron
can be toxic and contribute to the development of serious health problems such as liver
disease and diabetes. Even though excess iron is harmful, the human body is unable to
excrete consequential amounts of iron. Because of this, several regulatory mechanisms
exist to control and adjust dietary nonheme iron absorption in an effort to maintain
whole body iron balance, prevent toxicity, and optimize iron status. While our
understanding of the metabolic pathways regulating iron absorption and metabolism has
greatly improved in recent years, there are still many details left to be uncovered.
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Chapter 3
Effects of Dietary Components on Nonheme Iron Absorption

Introduction
Disorders affecting iron metabolism are among the most common nutrient
disorders worldwide. Some of the most prevalent include iron deficiency, anemia of
chronic disease, and hereditary hemochromatosis. These conditions are characterized
by either reduced iron stores or iron overload and are often caused by alterations in the
amount of dietary iron absorbed by the small intestine. Since improper iron absorption
is a major factor in the etiology and exacerbation of these disorders, identifying dietary
constituents that affect intestinal iron absorption is important for the development of
therapies aimed at improving iron status in individuals with iron imbalance.
Several dietary factors have been shown to impact iron absorption, the most
well-known being soy, ascorbic acid, minerals such as calcium and zinc, tannins,
phytates, and dietary protein. The purpose of this review is to provide an overview of
our current understanding of various nutrient effects on iron absorption and the
underlying mechanisms involved, with an emphasis on the effect of dietary protein.
Since heme iron bioavailability and absorption is for the most part independent of other
dietary constituents, the effect of diet on nonheme iron will be the focus of this paper.46

Dietary Iron Recommendations
The recommendations for dietary iron set by the Food and Nutrition Board of the
Institute of Medicine in 2001 are based on intakes necessary to maintain minimal levels
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of iron stores, rather than the lower amounts needed to prevent anemia.47 The
recommendations vary according to life stage and gender and take into account iron
losses, fetal requirements, increased requirements during growth, and/or increased
tissue and storage iron. For example, iron needs are higher for women of childbearing
age than for males in order to balance menstrual losses. Thus, the Recommended
Dietary Allowance (RDA) for iron is 8 mg/d for adult men and 18 mg/d for adult
premenopausal women. The group with the highest iron needs are pregnant women
whose RDA is set at 27 mg/d due to blood volume expansion, fetal and placental iron
requirements, and blood loss during delivery. Not surprisingly, individuals with higher
iron needs are also those most at risk for iron deficiency, which affects 4-5 billion people
globally and 9-16% of adolescent and adult females in the U.S.48,49 In addition to
increased iron needs due to menstrual losses, premenopausal women are probably at
increased risk for iron deficiency as a result of inadequate dietary iron intake. For
example, NHANES data from 2001-2002 indicate that approximately 15% of women
aged 19-30 have iron intakes below their Estimated Average Requirement (EAR) of 8.1
mg iron/d, which is the amount of iron expected to satisfy the needs of 50% of
individuals in that age group.50 Similarly, 17% of women aged 31-50 consume less than
the EAR. Therefore, higher iron needs coupled with insufficient dietary intake may
increase an individual’s susceptibility to iron deficiency.
Iron deficiency, which is the most common nutritional deficiency worldwide, is
characterized by depleted iron stores resulting in functional tissue iron deficit.
Complications of iron deficiency that cause a decline in health and quality of life include
progression to iron deficiency anemia, increased risk for preterm delivery and low birth
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weight in pregnant women, delayed infant motor/mental function, fatigue, reduced work
capacity, and impaired immune function.51 According to the World Health Organization,
anemia contributes to 20% of all maternal deaths.52 The current approach to treating
iron deficiency is to prescribe iron supplementation. However, iron supplements often
cause gastrointestinal side effects that reduce adherence. Since intestinal absorption is
a critical regulatory step in the maintenance of iron status, therapies aimed at enhancing
intestinal iron absorption may improve iron status in deficient individuals. Further, since
many adolescent and adult females do not consume enough iron to meet their needs,
the identification of factors that improve the availability and absorption of the iron they
do consume is necessary to help prevent iron deficiency in these individuals.

Dietary Factors that Inhibit Intestinal Iron Absorption
Phytate
Phytic acid is a widely distributed natural antioxidant found in grains and
vegetables and is the principal storage form of phosphorus in many plants. It has been
hypothesized that the inhibitory effect of phytic acid on iron absorption is due to the
formation of an insoluble complex between the two in the gastrointestinal tract.53
Several iron absorption studies in humans support this idea. In one study, reduction of
phytic acid content of soy isolate by acid-salt washing and ultrafiltration augmented iron
absorption by 2.1-fold compared to the control soy isolate with native phytic acid
content.54 Further, when the phytic acid was added back to the soy isolate, iron
absorption returned to its original amount. In a similar study seeking to define the role
of phytate in the inhibition of iron absorption, iron absorption was significantly better with
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dephytinized bran than untreated bran.55 In a separate study, phytic acid was
significantly negatively associated with nonheme iron absorption in adult men and
women (r = -0.38, P ≤ 0.0001), and multiple regression analysis revealed that 16.4% of
the variance in iron absorption was accounted for by phytic acid (P = 0.0001).56

Soy
Soy, a plant in the pea family that originated in China, has been a substantial
component of Asian diets for thousands of years. It was introduced to the American
colonies in the late 1700s and today accounts for 27% of the total crop area in the
country.57 Soy is used in a multitude of products including infant formulas, flours,
protein isolates and concentrates, and textured fibers. Soy-based foods include
cheese, drinks, miso, tempeh, tofu, and vegetarian meat substitutes. Many people
consume soy for its purported health and nutrition benefits, which have been reported to
include lowering plasma cholesterol, preventing cancer, diabetes, and obesity, and
protecting against bowel and kidney disease. Vegetarians and vegans favor soy and
soy products, as they are good quality, animal product-free protein sources. Aside from
being a high-quality protein source, soy contains bioactive proteins and secondary
metabolites such as isoflavones and phytic acid, which have been reported to be
beneficial for health. Even though processed soy proteins are bioavailable in humans,
their nutritional value is lower than that of milk protein, owing in part to the low content
of the essential sulfur-containing amino acid methionine. Additionally, while soy can be
a useful source of amino acids and other salutary nutrients, it has been shown to inhibit
nonheme iron absorption. In 1981, Cook et al. demonstrated that several soy products
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substantially inhibit nonheme iron absorption in humans.58 Specifically, when egg
albumin was substituted for by isolated soy protein, full fat soy flour, or textured soy
flour, iron absorption was reduced by 92%, 82%, and 65%, respectively. Substitution of
soy products for meat also has deleterious effects on iron absorption. When one-third
of the meat in a mixed meal is replaced by soy flour, there is a 62% reduction in
nonheme iron absorption.59
The mechanism by which soy inhibits nonheme iron absorption was first thought
to be due to its high phytic acid content. Although the high phytic acid content of soy
may partially explain the reduction in iron absorption seen with soy products, there are
likely other components of soy that contribute to its inhibitory effect. In support of this,
Hurrell et al. showed that removal of nearly all the phytic acid from soy-protein isolates
only improved iron absorption from 10-24% to 55% of the absorption from an egg whitecontrol meal, suggesting that soy protein itself suppresses iron absorption.54 The
authors suggest that the inhibitory nature of phytate-free soy isolate may be due to the
chelation of iron by insoluble peptides in the duodenum such as carboxylic acid groups.
Another report by Lynch et al. corroborates the idea that other factors are involved in
the inhibition of iron absorption by soy, and in particular, points to a protein-related
moiety.60 In this study, iron absorption was measured in adult volunteers consuming a
series of soybean protein hydrolysates and soy protein isolate. Absorption of iron was
greater with enzymatic hydrolysis of soybean protein compared to soy protein isolate,
and the improvement in absorption appeared to be linked to the extent of hydrolysis.
The investigators also examined the inhibitory role of two specific soy protein fractions,
glycinin and conglycinin, which are the major constituents of commercial soy protein
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isolate products. Compared to an egg white control meal, iron absorption in the
presence of glycinin was ~78% lower, and 68% lower with conglycinin. However, when
phytic acid content was markedly reduced in both fractions, iron absorption only
improved with the glycinin fraction, suggesting that conglycinin, independent of phytate
content, is partially responsible for impaired iron bioavailability associated with soybean
products.
In summary, while soy-derived foods are generally good sources of high-quality
protein and may provide additional health benefits attributable to their polyphenol
content, it is important to keep in mind that constituents of soy hinder iron absorption.
This effect appears to be a result of the formation of insoluble, unabsorbable complexes
between iron and phytates and/or iron’s interaction with conglycinin.

Tannins: coffee & tea
Like soy, coffee and tea are enjoyed by millions of people worldwide, making
them two of the most common beverages consumed. According to NHANES data from
2007-2008, approximately 50% of U.S. adult men and women drink coffee on any given
day, while ~30% drink tea.61 Worldwide, tea is the second most consumed beverage
next to water.62 Common reasons individuals may choose to drink coffee and tea
include the high caffeine content as well as for reported health benefits from the
phytochemicals present in both. However, as a result of decades of study, it is now
known that tea and coffee also prevent iron absorption in the gut. In 1975, Disler et al.
showed that drinking tea significantly hindered absorption of iron from both iron salts
and food.63 In a similar study, when tea was substituted for water and consumed with a
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hamburger meal, nonheme iron absorption fell from 3.71% to 1.32%, which represents
a 64% reduction in iron absorption (P < 0.001).64 Coffee also significantly inhibited iron
absorption from the hamburger meal, with a mean reduction of 39% compared to water.
The inhibitory effect of tea on intestinal iron uptake is thought to be due to tea’s
high tannic acid content. Tannins are polyphenolic compounds that form complexes
with ferric iron in the gut lumen, thus reducing iron solubility and bioavailability.63 To
determine if tannins play a significant part in the inhibition of iron absorption by tea, a
recent study directly examined the effect of tannin on iron absorption in rats.65 Rats
were randomized to one of four levels of tannic acid (5, 10, 15 or 20 g tannic acid/kg
diet) for 3 weeks and iron absorption assessed on days 11-13 and 19-21 of the
intervention using the iron balance method. Absorption analysis demonstrated a
striking reduction in iron uptake in animals consuming the 10, 15 and 20 g tannic acid
groups compared to control animals. Specifically, balance data from days 11-13
showed a significant 57% reduction in iron absorption in the 15 g tannic acid group and
a 53% reduction in the 20 g group compared to controls. Similarly, 3 wks of a high
tannic acid diet impaired iron absorption by 53% and 46% (15 g tannic acid/kg diet and
20 g tannic acid/kg diet, respectively), suggesting that tannins may in fact be partially to
blame for the suppression in iron absorption that occurs with tea intake. These findings
may be applicable to humans since the level of tannic acid given to rats was similar to
the usual intake of polyphenols by humans.
Coffee is thought to exert its inhibitory effect on intestinal iron uptake by affecting
iron solubility in the gut lumen, since studies show marked reductions in iron absorption
when coffee is consumed with a meal or 1 h postprandially.64 Coffee contains much
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less tannic acid than tea so it is less likely to be a major contributor to its effect on iron
absorption.

Minerals: calcium
Several minerals have also been demonstrated to hinder iron absorption
including calcium, manganese and zinc. The most extensively studied of these is
calcium. In the early 1970s, Monsen and Cook evaluated the effect of calcium and
phosphate salts on nonheme iron absorption in healthy men and women.66 Compared
to a control semisynthetic meal, there was a significant 47% reduction in nonheme iron
absorption upon addition of calcium and phosphate. Additionally, when calcium and
phosphate were added to a semisynthetic meal containing beef, iron absorption
decreased from 8.8% to 4.0% (P < 0.001). Interestingly, the single addition of either
calcium or phosphate did not significantly lower iron absorption compared to the level
observed when neither was added. The authors suggest that this could be explained by
the formation of a complex of calcium, phosphate, and iron and that greater amounts of
calcium are required to interfere with the absorption of iron on its own.
Another study by Cook et al. showed that in healthy adults, 300 mg calcium
carbonate significantly reduced iron absorption from a therapeutic dose of ferrous
sulfate (37 mg) by 24% when taken with food.67 Further, in individuals with depleted
iron stores, calcium carbonate inhibited iron absorption by 44% from 13% to 7.3%.
Surprisingly, calcium supplements only significantly hindered iron absorption when
taken with a meal. Thus, when calcium and iron supplements were consumed with
water, the inhibitory effect of calcium on iron absorption was absent. These findings
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suggest that adverse effects of calcium supplementation on iron absorption and
availability could be avoided if calcium supplements are ingested between meals.
Although soy, tannic acid, and calcium have been shown to negatively impact
intestinal iron absorption, the likelihood that these nutrient effects on iron assimilation
play a major role in the development of iron deficiency in healthy individuals is slim. For
example, it is thought that the inhibitory effect of soy may only be an important problem
in areas where soy is the major protein source or among individuals who do not
consume meat or ascorbic acid.58 Additionally, many of the abovementioned studies
analyzed the impact of dietary factors on iron absorption in the setting of a single meal.
It would be more informative and relevant to examine their effect in the context of the
whole diet. For example, when nonheme iron absorption was estimated during four 4-d
diet periods in which the diets differed in calcium content, no effect of a glass of milk or
of an equivalent amount of calcium from fortified foods on iron absorption was
observed.68 Additionally, there was no substantial effect of phytic acid on nonheme iron
absorption in this study, which is in disagreement with several prior reports on this
subject. Finally, the majority of observational and long-term supplementation studies do
not support a detrimental effect of calcium on iron status.69
Therefore, it appears that although these dietary components are capable of
inhibiting iron absorption, it is unlikely that they significantly contribute to the
development of iron deficiency in the majority of healthy individuals consuming a varied
diet. Nonetheless, it may be beneficial for those at high risk of iron deficiency to
consume foods and supplements containing these inhibitory factors separately from
those containing appreciable amounts of nonheme iron.
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Dietary Factors that Promote Intestinal Iron Absorption
Ascorbic Acid
Ascorbic acid, or vitamin C, is one of the single most important dietary factors
influencing iron absorption. Specifically, it has been recognized for decades that
ascorbic acid, which is found in high concentrations in citrus foods, enhances iron
absorption in the small intestine. In a 1977 report by Cook and Monsen, ascorbic acid
significantly augmented iron absorption in adult men.70 When consuming a
semisynthetic meal containing no meat, the increase in iron absorption was directly
proportional to the amount of ascorbic acid provided. Ascorbic acid consumption also
promotes iron absorption and balance in iron-depleted young women.71 In this study,
subjects’ iron stores were depleted by phlebotomy and by ingesting a low-iron diet until
serum ferritin was reduced to <8.5 μg/L. Following depletion, women were
supplemented with iron and provided with 1500 mg/d placebo or ascorbic acid for 40
days. Iron balance measurements revealed that women consuming ascorbic acid and
those consuming placebo absorbed 38% and 27% of ingested iron, respectively.
Additionally, the ascorbic acid group exhibited modestly improved iron status compared
to the placebo group, as evidenced by higher levels of hemoglobin, erythrocyte
protoporphyrin, zinc protoporphyrin, and serum iron. In a separate study designed to
generate a guide for estimating iron availability from meals, ascorbic acid was found to
explain 16.4% of the variation in intestinal iron absorption along with phytic acid and
meat (P = 0.0441). Increasing ascorbic acid content of a meal can also overcome the
inhibition of iron absorption caused by tannic acid and phytic acid.72 Ascorbic acid’s
enhancing effect on nonheme iron absorption is attributed to its ability to reduce iron
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from the ferric to the ferrous state, thus making it more available for uptake by the brush
border iron importer, DMT1.73,74 This effect of ascorbic acid is similar to that of the
enterocyte apical membrane ferrireductase, Dcytb. Therefore, individuals more
susceptible to iron insufficiency may consider increasing their vitamin C intake and
specifically, consuming ascorbic acid with meals, in order to maximize iron acquisition
from otherwise poor sources of bioavailable iron.

Dietary Protein
As early as 1903, it was suggested that protein breakdown products participate in
the absorption of iron.75 Since then, many investigators have explored the relationship
between dietary protein and iron, with a focus on protein’s effect on iron bioavailability in
the gastrointestinal tract. Experimental data support the conclusion that different
sources of protein have divergent effects on iron availability and absorption. This
section will outline the evidence supporting a role of dietary protein in intestinal iron
absorption, summarize the effects of various sources of protein on intestinal iron uptake,
and discuss potential mechanisms underlying these effects.

Meat protein and iron absorption
For decades, meat has been thought to influence iron bioavailability from food,
and specifically, to enhance its availability for absorption by the small intestine. This is
the so called “meat factor.” In 1968, Layrisse et al. showed that iron in black beans and
corn is better absorbed when combined with food of animal origin than when given
alone.76 In particular, adult subjects fed corn combined with either veal muscle or fish
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muscle exhibited a significant increase in iron absorption compared to corn alone, such
that iron absorption was ~50% greater when corn was given with veal, and ~300%
greater when given with fish (P < 0.01 and P < 0.001, respectively). Veal consumed
with black beans also significantly augmented iron absorption compared to black beans
alone, which amounted to a ~130% increase in absorption (P < 0.001).
Several years later, Gordon and Godber tested the hypothesis that beef
enhances nonheme iron bioavailability in the rat.77 Male Sprague Dawley rats were fed
a basal iron-deficient diet for one month followed by randomization to four experimental
diets. The experimental diets were prepared with soy protein or rice bran, to which was
added lactalbumin or freeze-dried washed beef to formulate 4 isoenergetic,
isonitrogenous diets of equal iron content. The four diets were provided ad libitum for
11 days. Iron balance experiments demonstrated that substituting washed beef for
lactalbumin in diets containing soy protein or rice bran caused a slight but nonsignificant
5% increase in apparent iron absorption. However, bioavailability analyses showed that
the relative biological value of iron in rice bran was significantly enhanced from 46% to
75% with the replacement of lactalbumin by washed beef (P ≤ 0.05). In humans, Cook
and Monsen also observed greater nonheme iron absorption with animal protein

compared to ovalbumin.78 Thus, when beef, pork, lamb, beef liver, chicken, and fish
were substituted for ovalbumin in a semisynthetic meal, mean absorption ratios
(substituted protein/ovalbumin) were 2.96, 3.21, 3.23, 3.77, 2.43, and 2.11, respectively.
In an effort to examine the enhancing effect of muscle tissue on nonheme iron
absorption using a complete diet rather than a single meal, Reddy et al. measured
nonheme iron absorption in adult men and women during 3 separate 5-d dietary
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periods.79 The 3 diets consisted of: 1) a freely chosen diet, 2) a vegetarian diet, and 3)
a diet in which meat, fish and poultry were increased maximally. Mean absorption
modestly increased from 4.81% on the self-selected diet to 6.47% on the high animal
meat diet (P = 0.075). Mean absorption during the meat-free diet (5.09%) was similar to
the self-selected diet. Using stepwise multiple regression analysis, animal tissue intake
was the only factor found to significantly affect nonheme iron absorption. A potential
explanation for the rather modest effect of animal meat on iron absorption in this study
is the high variability in absorption values between subjects. The percent absorption
ranged between 1.2-32.2%. Additionally, the subjects were all iron replete, which could
make it more difficult to capture an enhancing effect of meat if one exists.
Since it is known that the concentration of heme iron is high in meat, and that it is
highly bioavailable, it was once hypothesized that heme could be the elusive “meat
factor”. To address this possibility, Hurrell et al. investigated the influence of animal
tissue and heme on iron absorption in human subjects.80 Briefly, iron absorption was
measured in adult volunteers randomized to consume 4 test meals including one of egg
albumin plus 3 meals of either chicken protein fractions or beef protein fractions. The
chicken protein fractions consisted of 1) freeze-dried chicken muscle, 2) isolated
chicken muscle protein, and 3) heme-free chicken muscle protein, while the beef
fractions were 1) freeze-dried beef muscle, 2) isolated beef muscle protein, and 3)
heme-free beef muscle protein. Compared to the egg albumin control meal, all chicken
and beef protein fractions significantly augmented iron absorption. Interestingly, iron
absorption from the heme-free chicken and heme-free beef muscle protein fractions
was found to be significantly greater than that from their respective freeze-dried muscle
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protein fractions containing heme (difference= 2.2-fold for chicken, 1.2-fold for beef),
suggesting that heme or its degradation products are not responsible for the enhancing
effect of meat on nonheme iron absorption. The authors propose instead that the meat
factor is protein-related and that partially digested peptides from muscle proteins are
involved. Specifically, it was hypothesized that cysteine and histidine residues present
in meat peptides released during digestion may bind iron and form complexes that are
more soluble and available for absorption. This idea is supported by an earlier clinical
trial in which it was found that cysteine plus methionine significantly increased
absorption of black bean iron compared to iron absorption from black beans alone.81
Further experimental evidence supporting an effect of cysteine on iron availability can
be found in an in vitro study by Glahn et al., who used Caco-2 cells to define the effects
of various amino acids and dipeptides on iron solubility and iron uptake from ferrous and
ferric forms of iron.82 Solubility analyses demonstrated that the addition of cysteine and
reduced cysteinyl glycine to an insoluble FeCl3 solution improved iron solubility from
1.9% to 17% and 9.8%, respectively. Further, when cysteine was added, iron uptake by
Caco-2 cells increased 3.2-fold from an FeCl3 solution and 1.6-fold from an iron
nitrilotriacetic acid (Fe3+ NTA) solution. Reduced cysteinyl glycine also augmented iron
uptake from the FeCl3 and Fe3+ NTA transport solutions by approximately 2-fold. The
enhancing effect observed in this study appears to be due to a combination of an
increase in iron solubility, and the ability of cysteine and reduced cysteinyl glycine to
reduce iron from the unabsorbable ferric form to the more bioavailable ferrous form. An
enhancing effect of cysteine and reduced cysteinyl glycine on solubility cannot be the
only mechanism by which these amino acids enhance iron absorption, since Fe3+ NTA
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is highly soluble on its own (99% soluble). Neither cysteine or reduced cysteinyl glycine
changed the solubility of Fe3+ NTA, but both significantly improved iron uptake from this
solution. Therefore, it is more likely that for Fe3+ NTA, cysteine and reduced cysteinyl
glycine most likely served as ferrireductases, converting ferric iron to ferrous iron, thus
making it more available for uptake by brush border enterocytes.
An earlier study by Kapsokefalou and Miller supports the hypothesis that meat
improves nonheme iron absorption in part by altering its valence in the gut lumen.74 In
particular, it was found that under simulated gastrointestinal conditions, meat and
hemoglobin increased Fe2+ production from FeCl3 by 6-fold, while ascorbic acid and
cysteine induced a 12-fold increase in Fe2+ over the control. Although findings from this
study support the hypothesis that hemoglobin may improve iron absorption by reducing
it to the ferrous form, it is worth noting that the ferrous iron produced from hemoglobin
was only half as dialyzable as that produced from ascorbic acid and cysteine.
Dialyzability of iron following in vitro digestion has been reported to reflect iron
bioavailability and absorption in humans.83
Another candidate that may be involved in promoting nonheme iron absorption is
a meat fraction known as L-α-glycerophosphocholine, a hydrolytic product of lecithin.84
After being identified as contributing to a significant increase in iron absorption in Caco2 cells, L-α-glycerophosphocholine was added to vegetarian lasagna and administered
to adult women with low iron stores. Nonheme iron absorption from the lasagna meal
was evaluated using stable iron isotopes and calculated based on RBC incorporation of
the isotope 14 days later. Absorption analysis revealed that addition of L-αglycerophosphocholine to vegetarian lasagna increased iron absorption by 1.4%
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compared to control lasagna containing no L-α-glycerophosphocholine (P = 0.023).
Interestingly, the effect of L-α-glycerophosphocholine on iron absorption was not
significantly different from that observed with ascorbic acid. These findings should be
physiologically relevant as the amount of L-α-glycerophosphocholine added to the
lasagna meal was equivalent to the amount found in a medium portion of meat. The
authors suggest that the mechanism of action may be increased iron bioavailability as a
result of chemical binding, since divalent metal ions are able to bind to lecithin and
phosphatidylcholine.85
In summary, it is now known that animal tissue facilitates the absorption of iron
from food sources containing otherwise poorly bioavailable nonheme iron. Many
reports support that the effect of the meat factor is a luminal improvement in nonheme
iron availability, which may be a consequence of 1) the formation of highly soluble
complexes of iron and peptides/amino acids, and/or 2) the reduction of ferric iron to the
more absorbable ferrous form. The constituent responsible for the meat factor has not
been completely characterized, however promising contenders include: cysteine,
reduced cysteinyl glycine, and L-α-glycerophosphocholine.

Milk protein and iron absorption
Unlike meat, it is generally believed that milk protein inhibits iron absorption. For
example, as part of the study evaluating the effect of animal tissue on iron absorption,
Cook and Monsen observed a marked reduction in iron absorption when milk and
cheese were substituted for beef.78 Whole milk suppressed iron absorption by ~71%,
while the suppression by American cheese was ~62%. Several years later, the effect of
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the two major bovine milk protein fractions (whey and casein) on iron dialyzability under
simulated gastrointestinal conditions and on the absorption of iron by humans was
evaluated.86 Substitution of casein and whey products resulted in dialyzable iron values
that were 6-17% and 26-48% of the value obtained for egg white, respectively. Percent
iron absorption in human subjects was reduced by the substitution of casein and whey
for egg white, with mean absorption values falling from 6.67% with egg white to 3.65%
with casein, and 2.53% with egg white to 0.98% with whey. (Absorption values from
egg white were lower in the whey study since several of the participants were male with
higher serum ferritin levels compared to those in the casein study). The apparent
reduction in iron dialyzability and absorption could be partially mitigated via hydrolysis of
the casein and whey proteins. Maximum dialyzable iron was 17.2% with 90% acidhydrolyzed casein and 12.8% with 70% enzyme-hydrolyzed whey protein. Enzymatic
hydrolysis of casein also significantly improved iron absorption compared to sodium
caseinate by 2-fold, whereas hydrolysis of whey improved absorption 1.7-fold compared
to intact whey (P > 0.05 for whey). These findings were of the first to suggest that
bovine casein and whey proteins are at least partially responsible for the poor
bioavailability of iron in dairy products such as milk, and that hydrolysis of these proteins
to smaller peptides and amino acids prior to ingestion may improve iron bioavailability
and absorption.
Since these findings have significant public health import, due in part to the fact
that casein and whey typically serve as protein sources in commercial infant formula,
recent investigations have focused on the effect of hydrolyzed casein and whey on
nonheme iron absorption. As a result, it is now recognized that hydrolysis of the two
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different cow milk caseins, αs- and β-casein, yield different caseinophosphopeptides
(CPPs) that also differ in terms of their impact on iron absorption. In 2005, Kibangou et
al. reported results from a study in which the effect of β-casein-derived CPP and αscasein-derived CPP on in vivo and in vitro duodenal iron uptake was investigated.87
The in vivo study utilized a rat intestinal loop, which was perfused with either Fe
gluconate (control), Fe−αs1-CPP or Fe−β-CPP for 2h. Iron uptake from the 3 solutions
was evaluated by measuring iron concentrations in the perfusion solute, digestive
effluent, and mucosa of the perfused segment. Total uptake and net absorption of Fe
from Fe−β-CPP were greater than that from Fe gluconate, but these differences were
not statistically significant. The differences in total uptake and net absorption between
Fe−αs1-CPP and Fe−β-CPP were significant, however, with absorption from Fe−αs1CPP only reaching 50% of the absorption value of Fe−β-CPP. For the in vitro study,
Caco-2 cells grown on transwell inserts were exposed to Fe gluconate, Fe−β-CPP or
Fe−αs1-CPP for 2h, after which iron uptake and cellular iron retention was measured.
Differences observed between the CPPs in the in vitro study were more pronounced
than those of the in vivo perfusion study. For example, total iron uptake from Fe−αs1CPP was only 28% of the amount seen with Fe−β-CPP, and net absorption only
reached 40% of that with Fe−β-CPP (P < 0.05). These data are in agreement with
those from a more recent in vitro study assessing the effect of CPPs on iron availability
in Caco-2 cells.88 Compared to iron sulfate treatment, αs1-CPP, αs2-CPP, and β-CPP all
significantly augmented cellular ferritin synthesis, with β-CPP being the most effective.
It has been suggested that the effect of CPPs on iron absorption results from
their ability to bind to divalent metals like iron via a sequence of phosphoserine and
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glutamic acid residues. This complex formation sequesters iron, thus preventing iron
chelation by other dietary factors that would render it insoluble. It has also been
hypothesized that the iron-CPP complex may be absorbed intact by the enterocyte via
endocytosis.89 Although αs-CPP and β-CPP are similar in sequence and function, their
observed differential effects on enterocyte iron uptake may be due to different structure
and/or conformation in solution. Additionally, it was proposed that the greater
electronegative property of αs1-CPP arising from additional phosphoserine residues
could produce a tight iron-peptide complex and thus, hinder iron availability for
absorption compared to β-CPP.
In summary, although early studies demonstrated an inhibitory effect of milk
protein on nonheme iron absorption, recent data support that the influence is dependent
on whether the milk proteins (casein and whey) are intact or hydrolyzed. Hydrolyzed
casein/whey may promote iron absorption by binding it and improving iron solubility in
the gut, thus making it more readily available for absorption by enterocytes.

Dietary protein level and iron absorption
Although dietary protein’s impact on nonheme iron bioavailability has been
studied extensively, less is known about the effect of altering the amount of dietary
protein consumed on intestinal iron absorption. To answer this question, Klavins et al.
undertook iron absorption studies in rats consuming 5, 10, 15, 20 and 25% protein as
casein for 4 wks. In the first experiment, liver iron content at wk 4 was used as a
surrogate for iron absorption, while in the second, the iron content of the entire carcass
was used.75 In experiment one, animals consuming diets containing 5 and 10% protein
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exhibited significantly less hepatic iron content compared with their pair-fed controls
consuming an 18% protein diet. In contrast, there was no difference in liver iron content
between rats on the 15 and 25% protein diets compared to those on the 18% diet.
Experiment two showed significant differences in total body iron levels in rats
consuming the 5 and 10% protein diets compared to rats consuming 15, 20, and 25%
protein. Lower liver and total body iron content seen in the lower protein groups
suggests that iron absorption was impaired in these animals and that at least 15%
dietary protein is necessary to meet iron absorption needs. These findings confirm
those of another study which showed that the amount of iron incorporated into the
blood, mucosa of the small intestine, and adrenal glands was greater in rats fed diets
containing 20 and 40% casein than in animals fed diets containing 5% casein.90

Summary and Conclusions
Iron is a trace mineral important for a variety of biological functions. The balance
of iron within the body is largely dependent on the regulation of duodenal iron
absorption, which can be altered in response to changing iron requirements. Although
intestinal iron absorption is physiologically controlled through various hormonal and
local signals in response to body iron status, iron absorption can also be affected by
dietary factors, which either enhance or inhibit iron uptake. Components of the diet that
inhibit iron absorption include soy protein, phytates, tannic acid, and calcium while
components that improve iron uptake include ascorbic acid and meat protein. The
mechanism by which these factors affect nonheme iron absorption is mainly by altering
its bioavailability in the GI tract. Elucidation of these nutrient effects on iron absorption
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and the mechanisms involved is important for the development of therapies aimed at
improving iron status in deficient (or iron overloaded) individuals. For example, patients
with hereditary hemochromatosis should avoid consuming orange juice with meat, as
this will likely exacerbate the elevated uptake of dietary iron they already experience.
Alternatively, factors that are proven to have an enhancing effect, such as β-CPP, may
be exploited and used as nutraceuticals in iron deficient individuals.
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Chapter 4
Increasing Dietary Protein Acutely Augments Intestinal Iron
Transporter Expression and Significantly Increases Iron Absorption in
Rats

Introduction
Iron (Fe) deficiency is the most common nutritional deficiency worldwide and the
leading cause of anemia in the United States. While essential for a variety of biological
functions, excess Fe can be toxic to cells and whole body Fe balance is carefully
regulated. No physiologic Fe excretion mechanism exists in mammals, thus regulation
of intestinal absorption is crucial for maintaining Fe homeostasis.
The pathway of nonheme duodenal Fe absorption has been well characterized.
At the brush border membrane of enterocytes, nonheme ferric Fe (Fe3+) is reduced to
ferrous Fe (Fe2+) by an apical membrane-bound ferric reductase, duodenal cytochrome
b (Dcytb).11 Once in the ferrous form, the Fe is imported into the enterocyte by the
integral membrane protein, divalent metal transporter 1 (DMT1).12,13 In the cytosol, the
Fe may be stored bound to ferritin or exported to the circulation via ferroportin 1 (FPN1),
located on the basolateral cell membrane.14 Reduced Fe is then re-oxidized by the
ferric oxidase, hephaestin, to the ferric form and bound to apotransferrin for transport
through the circulatory system.15 The transferrin-bound Fe may then be taken up by
tissues expressing the transferrin receptor (TfR) via receptor-mediated endocytosis.16
The regulation of intestinal nonheme Fe absorption has been extensively studied.
One key regulator of Fe absorption is hepcidin, a 25-amino acid peptide hormone
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produced by the liver in response to Fe overload and inflammation.91 Hepcidin acts by
binding to FPN1 on the basolateral membrane of enterocytes and induces its
internalization and degradation.28 This in turn results in reduced basolateral Fe export
leading to increased cytosolic Fe in enterocytes. This rise in cellular Fe suppresses
DMT1 expression, which reduces intestinal Fe absorption. Additionally, changes in
hepcidin expression have recently been found to be associated with changes in Dcytb
expression. Specifically, reduced hepcidin expression was associated with significant
increases in DMT1 and Dcytb transcript expression in mice.92
A number of environmental factors have been shown to regulate iron absorption
and metabolism. As an example, hypoxia has been shown to affect iron metabolism by
transcriptionally regulating DMT1 expression.44 Dietary factors have also been shown
to impact Fe absorption. Ascorbic acid and meat protein enhance Fe absorption by
improving its solubility in the gut.78,93,94 Additionally, milk peptides produced during
enzymatic digestion have recently been demonstrated to improve Fe absorption in
vitro.95 In particular, caseinophosphopeptides (CPPs) have been shown to increase Fe
absorption ex vivo and in vitro but the mechanisms involved, and the specific CPPs
responsible, remain unclear.89 One hypothesis is that CPPs directly enhance Fe
solubility by strongly chelating and protecting Fe from physiological changes associated
with decreased Fe absorption.74,96
To our knowledge there have been no reports of dietary protein modifying the
expression of genes involved in Fe metabolism. In fact, it was reported that milk
peptides have no effect on the expression of the main Fe transporter DMT1.97 The
specific aims of this study were to re-evaluate the effect of increasing dietary protein on
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Fe absorption in a rat model and to determine if varying levels of dietary protein alter the
expression of any genes involved in Fe metabolism using microarray technology.

Materials and Methods
Experimental animals and diets
The diet study protocol and experimental diets used in this work have been
previously described by our group.98 Briefly, 250-300 g adult female Sprague Dawley
(SD) rats (n = 73) were purchased from Charles River Laboratories, Inc. (Wilmington,
MA, USA). Animals were housed in the Yale Animal Resource Center and cared for in
accordance with institutional animal care use policies. All experiments were approved
by the Yale Institutional Animal Care and Use Committee. Upon arrival, rats were
placed on standard diet 2018 Teklad Global 18% Protein Rodent Diet (Harlan Teklad,
Inc., Madison, WI, USA) for a minimum of 2 weeks to allow for acclimation. For all
studies, experimental diets were obtained from Harlan Teklad, Inc. and were
nutritionally complete and isocaloric (Table 1). The 5% protein level was chosen to
represent a low protein diet because it is the minimum level of protein required to
ensure normal growth.99 The 20% protein diet was used as a normal or moderate
protein diet and was representative of the standard rat diet 2018, which contains 24%
protein. The 40% protein diet was used as the high protein diet. The 5% and 20%
protein diets were made isocaloric to the 40% protein diet by the addition of cornstarch.
Lipid from corn oil was held constant in all diets at 14-15% of total calories. The three
diets were analyzed for total Fe content using the same method used to determine fecal
Fe detailed below.
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Although corn, wheat and soy represent the main protein sources of the standard
diet mentioned above (no. 2018; Harlan Teklad, Inc., Madison, WI, USA), casein was
chosen as the protein source of the 5%, 20% and 40% experimental diets used in the
studies reported here for the following reason. The standard rat chow contains a high
concentration of Fe (0.200 mg/g diet) compared to the concentration that is sufficient for
growth and achieving maximal hemoglobin concentration (0.035 mg/g diet).100 Thus,
we elected to use casein as the protein source in all our experimental diets because we
wished to utilize a purified diet that was sufficient in iron but did not contain excessive
amounts that might obscure the effects of dietary protein. Casein was chosen as the
principle protein source since that is what Teklad typically uses in formulating
experimental diets.

Fe balance studies
Twenty-four adult female SD rats were randomly assigned to groups of eight with
each group receiving one of the three experimental diets, 5%, 20%, or 40% protein, for
7 days ad libitum with free access to tap water. During d 4-7 of the experimental diets,
rats were housed individually in metabolic cages, and feces collected over 4
consecutive 24-h periods.

Because negligible Fe is excreted in the urine, urine

collections and urinary Fe concentrations were not measured.

For fecal Fe

determination, feces were ashed for 24 h at 600° C. The ash was transferred to 50-ml
conical tubes, crushed, and acidified with 0.5 mol/liter HCl. The acidified ash was kept
at 4° C with continuous rocking for 36-48 h. The ash was then centrifuged at room
temperature at 450 X g for 6 min using a Gentra GP8R centrifuge (Thermo Scientific,
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Milford, MA, USA). The supernatant was collected and Fe concentration determined by
atomic absorption spectrophotometry (PerkinElmer Analyst 800; PerkinElmer Inc,
Norwalk, CT, USA). Food intake was determined by weighing the food daily from which
Fe intake was calculated using the known Fe content of the diets. The 4 days of fecal
Fe measurements were used to calculate Fe absorption by the following equation:
% Fe absorption= [(Fe intake-fecal Fe)/(Fe intake)] X 100

Fe stable isotope absorption studies
For Fe absorption studies, 22 adult female SD rats were randomly assigned to
either a 20% or 40% protein diet for 12 days. The diets were identical to those utilized
in the Fe balance study but were formulated to contain an equivalent amount of Fe
(~0.036 mg/g diet). Three rats were used as controls and remained on standard rat
chow (24% protein) for the duration of the study following the 2 wk acclimation period.
Body weights were measured at baseline and on days 7 and 12 of the experimental
diets. The Fe isotope (57Fe at 88% enrichment) was purchased as metal from Trace
Sciences International (Richmond Hill, Canada) and converted into a sterile, pyrogenfree solution of ferrous sulfate by Anazao Health Corporation (Tampa, FL, USA). The
isotopic composition of the tracer solution was validated with the use of a ThermoQuest
Triton TI Magnetic Sector Thermal Ionization Mass Spectrometer (ThermoQuest
Corporation, Bremen, Germany). On d 7 of the diets, 100 μg
administered through a 16 gauge, 3-inch gavage needle.

FeSO4 (2.5 μg/μl) was
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Following oral gavage,

animals were placed in metabolic cages for 5 d to prevent copraphagy. On d 12, rats
were anesthetized using 30% V/V isoflurane and blood was collected.
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Serum was

separated for biochemical analyses and 0.5-1 mL of whole blood was utilized to
determine RBC enrichment of
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Fe by magnetic sector thermal ionization mass

spectrometry as described previously.101
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The quantity of

erythrocytes (mg) was determined using the measured RBC

Fe incorporated into
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Fe enrichment and an

estimation of total circulating Fe based on an assumed blood volume for female SD rats
of 78.4 mL/kg102, the Fe concentration of hemoglobin (3.47 g/kg), and by measuring
each animals’ hemoglobin (in g/L) and weight (in kg) using the following formula:
Total circulating Fe =78.4 ml/kg X wt (kg) X Hb (g/dL) X 0.01 X 3.47 (g/kg).
The final calculation for Fe absorption was determined based on the assumption that
80% of the absorbed isotope was incorporated into erythrocytes.

Blood parameters of iron metabolism
To determine if altering dietary protein in the short term results in changes in
serum indicators of Fe status, blood and serum were obtained from 6 rats utilized in the
stable isotope absorption studies (n = 3 per group) as well as from six additional
animals consuming either the 20% or 40% diet for 7 days. Hemoglobin was measured
in whole blood using a commercially available colorimetric assay (DIHB-250, BioAssay
Systems, Hayward, CA, USA) and the VICTOR3TM Multilabel Plate Reader
(PerkinElmer, Waltham, MA, USA). Serum Fe, total iron-binding capacity (TIBC), and
% transferrin saturation were measured in the Yale New Haven Hospital Clinical
Chemistry Laboratory using an autoanalyzer.
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Whole genome microarray
In a broader effort to understand dietary protein’s effects on genes involved in
mineral homeostasis, one of us (E.G.-S.) conducted a whole genome microarray screen
using RNA isolated from the duodenal mucosa of rats consuming different levels of
dietary protein. Eighteen rats were randomized to either a 5% or 40% protein diet for 1
wk. On d 7 of the diets, rats were anesthetized, the abdominal cavity opened and the
first 10 cm of the small intestine distal to the pyloric sphincter removed. The intestine
was placed on a plastic tray on ice, and mucosal tissue removed by scraping. The
mucosa was snap frozen in liquid N and stored at -80° C until analysis. For total RNA
extraction, mucosa was ground in liquid N using a mortar and pestle and extracted with
TRIzol (Invitrogen, Carlsbad, CA, USA) followed by purification using the RNeasy Mini
Kit (QIAGEN, Valencia, CA, USA). The quality of RNA isolated from individual mucosa
was assessed by microcapillary gel eletrophoresis and determined to be suitable for
microarray analysis (28S:18S = 2:1, OD 260/280 > 1.8, OD 260/230 > 1.8).

Four

micrograms of RNA from three rats in each diet group were pooled such that there were
three pooled RNA samples from each experimental diet with each diet pool analyzed on
a single microarray chip. Thus, there were 3 chips for the low protein group and 3 chips
for the high protein group, with each chip representing a pool of RNA from 3 animals.
The pooled RNA samples were reverse transcribed to cDNA and hybridized to the
Affymetrix GeneChip Rat Expression Set 230 2.0 per company protocol. Raw signal
intensity values were imported into GeneSpring® X (Agilent Technologies, Santa Clara,
CA, USA) and RMA normalization was applied. The normalized signals were then
filtered by probe sets for a signal > 100 in at least one sample per condition and then
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analyzed by student’s t test (P <0.05). The resulting list of significantly regulated genes
was filtered by fold change of at least 1.5.

RNA isolation and quantitative real-time PCR
To confirm the findings of the gene profiling study, qPCR was performed on the
same RNA pools utilized in the microarray. Since the microarray analysis included rats
acclimated only to 5% and 40% protein diets, RNA was also prepared from the
duodenum of 6 additional animals acclimated to a 20% protein diet (moderate protein
diet) for 1 wk. cDNA was synthesized using the AffinityScript QPCR cDNA Synthesis
Kit (Stratagene, La Jolla, CA, USA), and the reverse transcription reaction performed on
a PTC-100 PCR machine (MJ Research, Inc., Waltham, MA, USA) using the following
protocol: 25° C for 10 min, 43° C for 45 min, and 95° C for 5 min. QPCR was performed
using

Taqman®

Gene

Expression

Assays

for

the

following

targets:

DMT1

(Rn00565927_m1), Dcytb (Rn01484657_m1), and TfR (Rn01474701_m1) (Applied
Biosystems, Foster City, CA, USA) and Brilliant® QPCR Master Mix (Stratagene, La
Jolla, CA, USA). Intestinal-specific alkaline phosphatase was used as an endogenous
reference (Rn00575326_g1, Applied Biosystems, Foster City, CA, USA).

The PCR

reactions were run using an Opticon2 machine (MJ Research, Inc., Waltham, MA, USA)
and the following protocol: 95° C for 10 min, followed by 40 cycles at 95° C for 20 sec
and 60° C for 1 min.
To determine if dietary protein selectively changed the levels of expression of the
DMT1A-IRE and DMT1A-nonIRE isoforms, additional real-time PCR analyses were
undertaken using duodenal RNA isolated from 7 rats consuming the 20% protein diet
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and 8 rats consuming the 40% protein diet. cDNA was synthesized as described above
and qPCR was performed using SYBR® Green Master Mix and the following primers:
DMT1A-IRE forward primer 5’ GGTTAGCGTGGCTTATCTGG 3’, reverse primer 5’
TGTGCAACGGCACATACTTG

3’;

DMT1A-nonIRE

forward

primer

5’

AAGGCGAAGAAGATCTGGAG 3’, reverse primer 5’ CCACAGGCCCGCTGTTTG 3’.
Rat β-actin was used as an endogenous control. The reactions were run using an iQ2
Optical System (Bio-Rad, Hercules, CA) and the following protocol: predenaturation at
95° C for 10 min, followed by 40 cycles of 15 sec denaturation at 95° C, annealing at
55° C for 1 min, and final extension at 72° C for 30 sec.

Statistical Analysis
Statistical analyses were performed using GraphPad Prism version 4.0a
(GraphPad Software, Inc., La Jolla, CA, USA). When three groups were studied, results
were analyzed using one-way ANOVA. If a significant F statistic was obtained, post hoc
analysis was performed using the Kruskal-Wallis test to make pair-wise comparisons
between groups. A Student’s t test was used to analyze experiments conducted on only
two groups.

For all statistical analyses, differences with a P value < 0.05 were

considered significant.

Data are reported as means ± SEM.

In the Fe isotopic

absorption studies, one animal was excluded from the final analysis because it was
considered an outlier since the calculated Fe absorption for that animal was greater
than three standard deviations above the mean for the group as a whole.
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Results
Fe balance studies
Fe balance data from rats consuming the 5%, 20% and 40% protein diets are
summarized in Table 2. At baseline, body weights were similar between the three diet
groups and mean weight gain was not significantly different among the three groups
(14.5 ± 5.90 g in the 5% group, 7.25 ± 2.40 g in the 20% group and 11.13 ± 2.17 g in
the 40% group; P = NS). The Fe content of the three diets did not differ significantly
and was 0.047 mg/g, 0.044 mg/g and 0.054 mg/g for the 5%, 20% and 40% diet,
respectively.

Average food intake (and thus Fe intake) during d 4-7 was also

comparable among the groups (Table 2). Mean fecal Fe excretion was significantly
higher in the 5% group compared to that in the 20% and 40% groups (4.31 ± 0.282 mg
vs. 3.07 ± 0.303 and 2.97 ± 0.223 mg, respectively; P < 0.05). As shown in Figure 1A,
iron absorption increased as dietary protein was increased from 5% to 20% to 40% of
total calories (7.3 ± 3.18 → 13.9 ± 11.2 → 30.8 ± 5.44%, respectively). The difference
in mean % Fe absorption between the 40% and 5% protein diets was statistically
significant (P < 0.01). However, the difference in absorption between the 5% and 20%
as well as that between the 40% and 20% diets was not significant.

Fe absorption studies
To more closely examine the difference in Fe absorption between the 20% and
40% protein diets using a more sensitive technique, stable isotopic Fe absorption
studies were conducted using rats randomized to either the 20% or 40% diet for 7 days.
Data from one animal in the 40% protein group was excluded from the final analysis
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because it was considered an outlier since the calculated Fe absorption for that animal
was greater than three standard deviations above the mean for the group as a whole.
There were no significant differences in baseline weights or weight change during the
12 d experimental period between the two diet groups.

However, there was a

significant difference in food intake and thus Fe intake between the two diet groups.
Animals on the 20% and 40% protein diets consumed an average of 19.2 ± 0.91 g diet
per day and 16.8 ± 0.65 g diet per day, respectively (P = 0.047). Fe intake was 0.69 ±
0.03 mg per day in the 20% group and 0.60 ± 0.02 mg per day in the 40% group (P =
0.046).

Despite a lower Fe intake, Fe absorption was significantly greater among

animals consuming the high-protein diet compared to animals consuming the mediumprotein diet (Figure 1B). Rats on the high-protein diet absorbed an average of 29.5 ±
8.5% of the administered
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FeSO4 while those on the medium-protein diet absorbed an

average of 17.9 ± 8.0% of the FeSO4 (P = 0.005). This would mean that on a highprotein diet, rats on average would absorb 0.177 mg Fe per day, given an intake of
0.600 mg of Fe, while animals on the medium-protein diet would absorb 0.107 mg per
day, for a net difference of approximately 0.070 mg per day between the two dietary
interventions.
To evaluate the possibility that differences in food intake between the high- and
medium-protein diets influenced results of the Fe absorption study, we performed a
subgroup analysis restricted to animals that consumed more than 16 g of food per day
(which represented 90.5% of the group as a whole). Only 2 animals, both from the 40%
protein group, consumed less than 16 g per day.

When these two animals were

eliminated from the analysis, there was no significant difference in food consumption
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between the 20% and 40% groups (P = 0.14), however the difference in Fe absorption
remained statistically significant (P = 0.003). These data indicate that the difference in
food consumption between the medium- and high-protein diet groups did not contribute
to the significant difference observed in Fe absorption.

Blood parameters of iron metabolism
There were no significant differences in hemoglobin, serum Fe, TIBC, or %
transferrin saturation between the 20% and 40% groups (data not shown).

Genes differentially regulated by dietary protein
A total of 208 genes were found to be differentially expressed in the 40% protein
group versus the 5% protein group. Of these 208 genes, 63 were upregulated and 145
were downregulated in the 40% group versus the 5% group. Three of the 63 genes
found to be upregulated by the high-protein diet are genes known to be involved in Fe
metabolism (DMT1, Dcytb, and TfR), while none of the downregulated genes are known
to be related to Fe homeostasis. In the high-protein group compared to the low-protein
group, DMT1, Dcytb, and TfR were upregulated by 3.2-fold, 1.8-fold and 1.8-fold,
respectively (Table 3).

QPCR analysis of the same RNA samples used in the

microarray screen confirmed that the expression of these three genes was significantly
higher during the high-protein diet compared to the low-protein diet. As summarized in
Figure 2, DMT1 was upregulated by 4-fold in the 40% group compared to the 5% group
while Dcytb was upregulated by 3.4-fold and TfR was upregulated 1.8-fold. These
changes are very comparable to those observed in the microarray screen. Because
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DMT1 and Dcytb were significantly upregulated in the initial microarray screen,
additional studies were done to further characterize the impact of dietary protein on their
expression levels.

Duodenal DMT1 and Dcytb mRNA expression
Since the microarray study only included animals on low- and high-protein diets,
the possibility existed that the difference in the expression of DMT1 and Dcytb between
the groups was due to suppression in the 5% group rather than induction in the 40%
group.

Therefore, we studied 6 additional animals after they had ingested a 20%

protein diet for 1 wk and used total RNA isolated from the duodenum of these animals
to quantify expression of DMT1 by qPCR. As summarized in Figure 3A, duodenal
DMT1 mRNA expression was found to be significantly different among the 5%, 20% and
40% diet groups (P < 0.01 by one-way ANOVA). Further, by post-hoc analysis, DMT1
expression was significantly higher in the 40% protein group versus the 20% protein
group with a fold difference of 3.8 (P < 0.001). QPCR was also performed to evaluate
expression of Dcytb using duodenal RNA isolated from 7 rats consuming the 20%
protein diet and 9 rats consuming the 40% protein diet in the Fe absorption study. As
shown in Figure 3B, animals consuming the 40% protein diet exhibited significantly
greater Dcytb expression compared to those consuming the 20% protein diet (fold
change 1.7; P < 0.05). These data indicate that a high-protein diet augments duodenal
DMT1 and Dcytb expression compared to both low- and medium-protein diets.
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Dietary protein selectively upregulates the IRE containing isoform of DMT1
Two DMT1 isoforms have been reported to be expressed in the rat duodenum,
one containing an iron-responsive element (DMT1A-IRE) and a non-IRE isoform
(DMT1A-nonIRE). To determine if there was a difference in the expression levels of
these two DMT1 isoforms in response to dietary protein, isoform-specific qPCR was
undertaken using duodenal RNA isolated from 7 rats consuming the 20% protein diet
and 8 rats consuming the 40% protein diet. As shown in Figure 4, DMT1A-IRE was
selectively and significantly upregulated in response to increasing dietary protein by 2.8fold (P < 0.01). There was no significant change in the expression level of the DMT1AnonIRE isoform in response to dietary protein manipulation (data not shown).

Discussion
We found that in rats, acute changes in dietary protein significantly affected
intestinal Fe absorption and the expression of Fe-related genes. Specifically, animals
ingesting a high-protein (40%) diet for 1 wk exhibited a two-fold increase in Fe
absorption compared to rats on low- and medium-protein diets (5% and 20% protein,
respectively). This finding was confirmed using two different in vivo methodologies.
The observed augmentation in Fe uptake in the high-protein group was associated with
a significantly increased transcript expression for duodenal DMT1, Dcytb and TfR
compared to the low-protein group. Furthermore, the high-protein diet was associated
with a significant induction in duodenal DMT1 and Dcytb mRNA expression compared
to a medium-protein diet. These changes were not associated with alterations in
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biochemical markers of Fe status, which is not unexpected given the short duration of
the feeding studies and the overall adequacy of Fe content in the experimental diets.
To our knowledge, ours is the first study to demonstrate that increasing dietary
protein in the form of casein augments intestinal Fe absorption. The effect of protein on
Fe absorption has been extensively studied. However, most of these studies employed
single meal experiments in humans or have used in situ isolated intestinal loop
preparations in experimental animals.78,103 Several studies examined the impact of
various sources of dietary protein on Fe uptake in in vitro cell models, most notably
Caco-2 cells.95 Few studies have altered dietary protein using normal food sources
over several days to examine the effect on Fe absorption. Further, as noted in the
introduction, the emphasis in studies examining the relationship between dietary protein
and Fe economy has primarily been on the ways in which various protein sources alter
nonheme Fe bioavailability in the gut. For example, meat protein is well known to
enhance nonheme Fe absorption, however the mechanism is still unclear. The effect of
casein protein on Fe absorption has also been studied. Compared to meat protein
sources, the absorption of nonheme Fe is significantly reduced in the presence of
casein.78,86 Casein has been reported to chelate nonheme Fe and reduce its availability
for absorption. This is thought to be the basis for the observation that Fe absorption is
acutely reduced by the ingestion of cow’s milk.86 That notwithstanding, recent studies
have suggested that peptides produced during digestion of casein (CPPs and
hydrolyzed casein) may have divergent effects on nonheme Fe absorption. The two
main cow milk caseins are αs-casein and β-casein. Studies have shown that binding of
Fe to β-CPP improves Fe absorption compared to binding of Fe to α-CPP, which
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inhibits Fe absorption.89,103 Our study used a non-hydrolyzed casein-based protein diet.
Consequently, the data just reviewed regarding CPPs effects on Fe bioavailability raise
the possibility that our findings may in part be explained by the liberation of CPPs from
our diets. Prior data regarding CPPs were generated using isolated intestinal loop
models, so the relevance of these earlier studies to our in vivo data are uncertain. In
addition, if the principal effect of our high-protein diet was to improve Fe bioavailability
via a CPP-dependent mechanism, one would predict that this would cause suppression
of DMT1 expression. Since we found that DMT1 expression was increased in the highprotein group compared to the medium- and low-protein groups, it is unlikely that CPPdependent changes in Fe bioavailability meaningfully contributed to the observed
increase in Fe absorption. Our findings are interesting from a physiologic standpoint. It
may be that Fe absorption is enhanced with increasing protein intake since in a
nutritionally restricted environment (as was the case evolutionarily) both Fe and protein
are necessary for growth. Optimizing absorption of this key mineral would facilitate the
necessary expansion of Fe-dependent tissues such as the erythropoietic system.
A major finding of this study was that increasing dietary casein intake increased
enterocyte DMT1 expression. It is noteworthy that only the expression of the isoform of
DMT1 that contained an IRE (DMT1A-IRE) was upregulated by increasing dietary
protein. Iron restriction has been previously shown to augment the expression of
DMT1A-IRE, but other dietary perturbations that selectively upregulate this isoform to
our knowledge have not been reported. DMT1 is known to be critically important for Fe
metabolism. Thus, missense mutations in DMT1 in mk mice and Belgrade rats are
associated with severe Fe deficiency anemia.104,105 The mediators of dietary protein-
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induced DMT1 expression in vivo are at present unclear. One reasonable candidate for
an in vivo mediator of the changes that we observed is hepcidin. In particular, it is
possible that a high-protein diet suppresses hepatic expression of hepcidin. This in turn
would result in an increase in DMT1 expression and also explain the observed increase
in Dcytb and TfR transcript expression. We did not measure hepatic hepcidin
expression in our study so this possibility remains to be explored.
The strengths of this study include: 1) Two in vivo approaches were used to
confirm an effect of dietary protein on Fe absorption; 2) The microarray analysis was
robust given the large number of animals analyzed per chip, which reduced the
contribution of random biological variability to our findings; 3) The qPCR data were
entirely consistent with the findings in the microarray screen. One limitation of this
study is its short duration. The longest period in which rats were consuming
experimental diets was 12 days. Therefore, it is unclear whether the observed effects
would be sustained with long-term high-protein intake. If the dietary protein-induced
increase in Fe absorption was prolonged, it is difficult to predict if this would be
beneficial. Thus, studies exploring the effect of long-term consumption of varying levels
of dietary protein on Fe absorption and Fe status would help resolve these
uncertainties.
A second limitation is these studies employed rats and experimental diets, which
may not be necessarily generalizable to humans. However, it is worth noting that rats,
like humans, regulate Fe metabolism almost entirely by intestinal absorption, with little
contribution of urinary excretion.
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In summary, in this short-term animal model, we found that: 1) Increasing dietary
protein decreased fecal Fe excretion in balance studies; 2) The decrease in fecal Fe
excretion was consistent with an observed increase in intestinal Fe absorption as
determined using stable Fe isotopes; 3) Increasing dietary protein increased expression
of genes central to Fe absorption and metabolism; 4) The increase in duodenal Fe
absorption can be attributed, at least in part, to increased duodenal DMT1 and Dcytb
expression.
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FIGURE LEGENDS
Figure 1. Iron absorption in response to varying levels of dietary protein.
A) Percent iron absorption in rats consuming 5%, 20% and 40% protein diets for 1 wk.
Values are M ± SEM, n = 8 per diet group. Means without a common letter differ, P<
0.01. B) Percent 57Fe absorption was measured in rats following a 7-day period of a
20% or 40% protein diet. Values are M ± SEM, n = 11 in the 20% group, n = 10 in the
40% group. *P < 0.01.

Figure 2. QPCR confirmation of genes found to be differentially regulated by dietary
protein on the microarray screen. Statistical comparison is between the 40% and 5%
protein groups for each transcript. Values are M ± SEM, n = 9 per diet group. *P <
0.01, **P < 0.001.

Figure 3. DMT1 and Dcytb expression in response to varying levels of dietary protein.
A) Duodenal DMT1 mRNA expression in rats ingesting 5%, 20%, and 40% protein diets
for 1 wk. Values are M ± SEM, n = 9 in the 5% and 40% groups, n = 6 in the 20%
group. Means without a common letter differ, P < 0.01. B) Duodenal Dcytb mRNA
expression in rats ingesting 20% and 40% protein diets for 12 d. Values are M ± SEM,
n = 7 in the 20% group, n = 9 in the 40% group. *P < 0.05.

Figure 4. Duodenal DMT1A-IRE expression in rats consuming 20% and 40% protein
diets for 12 d. Values are M ± SEM, n = 7 in the 20% group, n = 8 in the 40% group. *P
< 0.01.
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Figure 3B
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TABLE 1. Experimental diets utilized in the iron balance and iron absorption
studies
Iron balance study

Protein source
Kcal/g diet

2018 Teklad
Global 18%
Protein
Rodent Diet
Corn, wheat &
soy
3.1

Stable isotope
absorption study

5%
protein

20%
protein

40%
protein

20%
protein

40%
protein

Casein

Casein

Casein

Casein

Casein

3.7

3.7

3.7

3.7

3.7

Protein (%)*
Carbohydrate
(%)*
Fat (%)*

24.0

5.7

22.0

43.3

22.0

43.2

58.0

80.6

63.9

42.2

64.2

42.2

18.0

13.7

14.1

14.5

13.9

14.6

Ca (%)

1.00

0.45

0.45

0.45

0.45

0.45

P (%)

0.70

0.35

0.35

0.35

0.35

0.35

Fe (mg/g diet)

0.200

0.047

0.044

0.054

0.038

0.038

*For macronutrients, % refers to percent of total kcal of diet.
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TABLE 2. Iron intake, fecal iron, and apparent iron absorption in response to various
levels of dietary protein assessed using the iron balance method
Dietary protein level
5% (n = 8)

20% (n = 8)

40% (n = 8)

4-d Fe intake (mg)

4.69 ± 0.355

3.77 ± 0.264

4.40 ± 0.309

4-d Fecal Fe (mg)

4.31 ± 0.282a

3.07 ± 0.303b

2.97 ± 0.223b

Apparent Fe
absorption (mg)

0.39 ± 0.19

0.70 ± 0.53

1.43 ± 0.34

Apparent Fe
absorption (%)

7.3 ±3.18a

13.9 ± 11.2a,b

30.8 ± 5.44b

Data are M ± SEM. Means in a row without a common letter differ, P<0.05.
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TABLE 3. Iron-related genes induced following ingestion of a 40% protein diet
detected by whole genome microarray screen
Unigene

Gene Symbol

Fold Change

TfR

Gene Title
solute carrier family 11
(proton-coupled divalent
metal ion transporters),
member 2
transferrin receptor

Rn.11418

Slc11a2
(DMT1)

Rn.98672
Rn.203500

Dcytb

duodenal cytochrome b

1.8
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3.2
1.8

Chapter 5
Acutely Increasing Dietary Protein Does Not Impact Iron Status in
Iron-Replete Postmenopausal Women

Introduction
Although the work just summarized indicates that increasing dietary protein
augments intestinal iron absorption in experimental animals, whether a short-term high
protein diet affects iron absorption and/or parameters of iron metabolism in humans has
not been investigated. Therefore, the purpose of this study was to evaluate if increasing
dietary protein improves iron status in humans by analyzing samples from a short-term
supplemental protein intervention trial recently conducted by our group. It was
hypothesized that the 10-day dietary protein intervention during this trial would be
associated with an improvement in markers of iron status.

Methods
Subjects and Design
Details of the study design and subject characteristics have been described
previously.106 Briefly, this clinical trial was a randomized, placebo-controlled, doubleblind, cross-over study consisting of two, 10-day dietary interventions of a moderate
protein diet to which was added either a whey-protein isolate powder or maltodextrin
control powder. The powder was added directly to the subject’s food, all of which was
prepared in the Yale New Haven Hospital Research Unit’s metabolic kitchen. After the
first 10-d experimental diet, participants followed a 2-wk washout diet prior to receiving
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the second 10-d experimental diet with the other supplement (protein or placebo).
Three timed 24-h urines were obtained between days 0 to 1, 6 to 7, and 9 to 10 of each
experimental period for measurement of creatinine and calcium, and fasting blood
samples were collected on days 1, 7, and 10 of each experimental period.
Ten healthy postmenopausal women participated in this study (mean age= 62 ±
7 years). Exclusion criteria was described previously and included women with dietary
protein intakes < 0.6 g/kg/day or > 1.0 g/kg/day, or a body mass index (BMI) > 32 or <
20.106 The study was approved by Investigational Review Boards at Yale University
(New Haven, CT) and the University of Connecticut (Storrs, CT). All participants gave
their written informed consent. Additionally, consent was provided for the analysis of
serum iron status indicators since this analysis was not part of the original study.

Diets
Subjects completed a 4-d food record before starting the study to assess their
usual nutrient intake; this was used to guide the design of the experimental diets. The
experimental diets contained between 0.6 g protein/kg and 1 g protein/kg, and matched
the subject’s usual intake of protein. The protein sources used for the experimental
diets were a typical mix of animal and vegetable sources. All subjects received a
multivitamin daily (One-A-Day 50 Plus, Bayer Nutritionals). Since the relationship
between dietary protein and urinary calcium excretion was a major outcome of this
study, dietary calcium and factors known to affect calcium metabolism were rigorously
controlled. For example, dietary calcium was kept in a range of 1,200 to 1,500 mg
through diet alone or, when necessary, with the addition of a calcium supplement
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(Tums, GlaxoSmithKline). Other nutrients known to affect calcium metabolism (e.g.,
sodium, phosphorus) and energy were matched to each subject’s usual intake. Fortyfive grams of whey protein (Proven 290, Glanbia Nutritionals, Inc.) or maltodextrin
(Maltrin M100 powder, Grain Processing Corporation) was added directly to the
subject’s foods/beverages each day throughout the experimental diet. Adding 45 g of
whey protein isolate to the experimental diet provided subjects with an additional 40 g of
protein. The whey protein isolate and maltodextrin (placebo) supplements were
formulated to achieve equivalent energy density (160 kcal/45 g) and equivalent content
of sodium (73 to 81 mg), potassium (182 mg), phosphorus (112 mg), and calcium (236
to 239 mg) expressed as per 45 g powder. Distilled water was provided ad libitum.
Subjects were also allowed to consume one serving of wine or beer per day.

Biochemical Assessment
Urinary nitrogen and urinary creatinine were measured previously by J.D.B.106
Serum hepcidin and serum ferritin were measured using commercially available
enzyme-linked immunosorbent assays (DRG International, Inc. and Ramco
Laboratories, respectively). Serum iron, total iron binding capacity (TIBC), and percent
transferrin saturation were measured at the Yale New Haven Hospital Clinical
Chemistry Laboratory using an autoanalyzer. To control for variability in the
completeness of 24-h urine collections, urinary excretion of nitrogen was expressed as
a ratio with creatinine excretion.
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Statistical Analyses
Analyses were performed using GraphPad Prism Version 6.0a (GraphPad
Software, Inc.). Paired sample t tests and simple linear regression were used to assess
differences between baseline and intervention and associations among serum
parameters and dietary factors. Non-normally distributed data were transformed prior to
linear regression analysis using the natural log. To evaluate associations between
serum parameters, Spearman rank correlation for nonparametric data was used. A
probability level of P < 0.05 was considered statistically significant. Data are presented
as mean ± standard deviation (SD) for normally distributed data and median [SD] for
non-normally distributed data.

Results
Participants
Ten subjects completed the study without difficulty. Body weight (71.3 ± 8.4 kg)
remained constant in all subjects throughout the study. The mean nutrient contents of
the experimental diets (exclusive of the study supplements) were as follows: protein
80.4 ± 19.4 g, iron 16.1 ± 1.1 mg, ascorbic acid 162 ± 20.9 mg, calcium 1,156 ± 124 mg,
phosphorus 1,206 ± 240 mg, sodium 2,528 ± 628 mg, magnesium 281 ± 48 mg,
potassium 2,800 ± 632 mg, and fiber 19.6 ± 5.5 mg. Within each subject, there were no
significant differences in the nutrient contents of the experimental food sources between
the two interventions.
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Serum Markers of Iron Metabolism
Serum iron status indicators at baseline and d10 of each intervention are shown
in Table 1. None of the 10 participants had depleted iron stores at any time during the
study, as every subject had a serum ferritin > 20 μg/L. Means for serum ferritin, serum
iron, TIBC, and % transferrin saturation at baseline and each intervention were within
normal limits. However, 3 subjects had serum ferritin levels greater than 150 μg/L,
which is a value associated with high risk of iron overload.107
As expected, serum values at baseline of each intervention did not differ.
Additionally, serum values at d10 of each intervention were not significantly different
from each other. There was a trend towards a greater mean TIBC level at d10 of the
protein intervention compared to the end of the placebo intervention, but this difference
did not reach statistical significance (median TIBC 301.0 μg/dL and 290.5 μg/dL,
respectively; P = 0.065). As shown in Table 1, within each intervention, there were no
significant differences between serum values at baseline and d10 of the experimental
diets.

Urinary nitrogen and markers of iron status
Since urinary nitrogen has been shown to be a valid indicator of protein intake,
relationships between urinary nitrogen and markers of iron status were assessed using
Spearman rank correlation. Results of this analysis revealed that urinary nitrogen
(corrected for creatinine) was negatively associated with serum ferritin (r = -0.315;
approximate P = 0.0479) and positively associated with TIBC (r = 0.332; approximate P
= 0.0365). However, linear regression analysis showed that urinary nitrogen was not a
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significant predictor of serum ferritin (Figure 1) or TIBC (not shown). Urinary nitrogen
was not significantly associated with the remaining iron status parameters measured
(hepcidin, serum iron, % transferrin saturation).

Dietary factors and markers of iron status
Linear regression analysis was performed to evaluate whether the consumption
of various dietary factors was associated with markers of iron status. Iron, meat, and
dietary protein intake were not significantly associated with d10 serum ferritin levels.
However, dietary ascorbic acid was significantly positively correlated with d10 serum
ferritin (R2= 0.33; P = 0.0119) (Figure 2).

Serum hepcidin and markers of iron status
Hepcidin is a critical negative regulator of iron absorption and metabolism.
Therefore, we tested whether serum hepcidin levels were associated with other markers
of iron status. Correlation analysis showed that serum hepcidin was significantly
positively correlated with serum ferritin (r = 0.619; approximate P < 0.0001) (Figure 3)
and negatively correlated with TIBC (r = -0.502; approximate P = 0.0010), whereas no
significant relationships were observed between serum hepcidin and serum iron or
between serum hepcidin and % transferrin saturation.

Discussion
Increasing dietary protein in the short-term had no effect on iron status in this
population of healthy iron-replete postmenopausal women. Thus, serum markers of
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iron status were not altered in response to 10 days of a high protein diet. Further, when
urinary nitrogen and dietary protein intake were regressed against serum ferritin, no
significant relationship was observed. However, a significant relationship was found
between ascorbic acid and iron status, such that vitamin C intake explained 33% of the
variability in d10 serum ferritin levels. Additionally, serum hepcidin was positively and
significantly correlated with serum ferritin, and negatively correlated with TIBC. In the
aggregate, these latter findings indicate that the dietary intervention was capable of
inducing some changes in parameters of iron metabolism.
The lack of a measurable effect of dietary protein on iron status in this study is in
agreement with findings from a recent in vivo rat study conducted by our group.
Although we saw an increase in intestinal iron absorption with increasing dietary protein
in rats, there was no effect of protein on markers of iron status.108 This suggests that
even though iron absorption may be enhanced in response to higher protein intake, a
longer duration study may be required to see a significant impact on iron status.
Another limitation of this study is the small sample size. Increasing the number of
participants may provide more power to observe a significant effect of dietary protein on
iron status.
Another possible explanation for the lack of an effect of protein on iron status in
this study is that the subjects were postmenopausal women and not iron deficient.
Postmenopausal women require less dietary iron than premenopausal women (8 mg/d
vs. 18 mg/d, respectively), since postmenopausal women do not need to compensate
for the iron losses that occur with menstruation. Therefore, it may be harder to detect
an effect of dietary protein in this population particularly if they are already iron replete.
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Thus, it may be more relevant to conduct a protein supplementation trial in iron deficient
women of childbearing age.
The finding that increasing ascorbic acid intake was positively associated with
serum ferritin levels is interesting. It has been known for decades that ascorbic acid
significantly enhances intestinal iron absorption in part by reducing nonheme iron from
the ferric form to the more bioavailable ferrous form. Therefore, it is not entirely
surprising that higher vitamin C consumption is associated with greater iron stores. A
previous study evaluating the effect of ascorbic acid on iron status in young women
showed that ascorbic acid supplementation augmented intestinal iron absorption but did
not affect serum ferritin levels.71 However, subjects in that study were iron deficient,
thus, the iron accumulated in response to ascorbic acid was most likely utilized to
replenish hemoglobin and serum iron pools, rather than to replenish storage iron pools
associated with serum ferritin. In contrast, participants in our study were not iron
depleted; therefore, any additional iron absorbed would most likely be stored in ferritin.
The statistically significant relationship between serum hepcidin and serum
ferritin observed in this study has been described by others.101,109 Since hepcidin is a
negative regulator of iron absorption, its positive association with serum ferritin is most
likely due to feedback responses resulting from elevated systemic iron status. An
alternative explanation may be the possible existence of low-grade inflammation among
study participants. Inflammatory signals augment both hepcidin and ferritin
concentrations in the circulation and inflammation is known to increase with age.
Unfortunately, we did not measure the levels of circulating inflammatory cytokines;
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therefore, whether inflammation was a contributing factor to the high levels of serum
ferritin observed in this study is unknown.
In summary, increasing dietary protein in the short-term does not significantly
impact iron status in postmenopausal women. However, longer duration
supplementation trials in individuals at high risk for iron deficiency should be performed
to more adequately address the effect of dietary protein on human iron metabolism.
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Table 1. Baseline and intervention measures of serum markers of iron status

Data are means ± SD (serum iron) and median [SD] (serum hepcidin, ferritin, TIBC, % transferrin saturation).

Figure 1. Linear regression analysis of serum ferritin and urinary nitrogen corrected for
creatinine (R2= 0.091, P = 0.059)
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Figure 2. Linear regression analysis of d10 serum ferritin and dietary ascorbic
acid (R2= 0.33, P = 0.0119)

Figure 3. Significant correlation between serum ferritin and serum hepcidin (r =
0.619; approximate P < 0.0001).
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Chapter 6
Amino Acids Directly Augment Duodenal DMT1 Expression and DMT1
Promoter Activity in Vitro

Introduction
As described in Chapter 4, increasing dietary protein from a medium (20%) to a
high (40%) level in rats significantly augments transcript expression of three genes
known to be involved in iron absorption and metabolism. Specifically, in the high protein
group compared to the medium protein group, DMT1 was upregulated by 3.8-fold,
Dcytb was upregulated by 1.8-fold, and TfR was upregulated by 1.6-fold (P < 0.05 for
each). Thus, the observed improvement in iron absorption with increasing dietary
protein in this experimental model can be attributed at least in part to increased
transcript levels of key duodenal iron transporters.
DMT1 was the focus of the following study since it was the most robustly
upregulated by the high protein diet and is the primary nonheme iron importer in the
enterocyte. The molecular mechanism(s) by which dietary protein induces duodenal
DMT1 expression is currently unknown. Therefore, the purpose of this study was to
determine if amino acids directly increase DMT1 mRNA and/or protein expression, and
if so, whether the effect is due to a change in transcriptional activity of the DMT1
promoter. It was hypothesized that Caco-2 cells incubated in media supplemented with
amino acids would exhibit an increase in DMT1 mRNA and protein expression
compared to cells incubated in the absence of added amino acids, and that this would
be due to activation of the DMT1 promoter.
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Materials and Methods
Cell Culture
Caco-2 Bbe cells were kindly provided by Dr. Mark Mooseker (Department of
Molecular, Cellular and Developmental Biology, Yale University). Caco-2 cells were
grown in T-75 flasks and routinely passaged using Trypsin/0.5% EDTA when 80-90%
confluent. Cells were cultured in growth media containing high glucose DMEM, 10%
qualified FBS, 1% L-glutamine, 1% non-essential amino acids and 1%
penicillin/streptomycin and media was changed every 2-3 days. For real-time PCR
analysis, Caco-2 Bbe cells were seeded into 6-well plates at a density of 5 x 105
cells/well and studied 18-22 days post confluent. This time point was chosen based on
work published by others showing that by d15 post confluence, Caco-2 cells transdifferentiate into a small intestinal phenotype with brush border microvilli and expression
of apical enzymes such as sucrose isomaltase.110 Once post confluent, Caco-2 Bbe
monolayers were exposed to either control media or amino acid-supplemented media
for 6 and 24 hours. Specifically, the control media was a physiologic saline solution
containing in mM: 25 glucose, 120 NaCl, 4.2 KCl, 1 L-glutamine, 1.1 CaCl2, 0.3 MgCl2,
0.4 MgSO4, 25 NaHCO3, 0.4 NaH2PO4, 0.5 Na2HPO4, and 1 glycine. The amino acidsupplemented media was prepared by the addition of a mixture of amino acids
(containing essential and non-essential amino acids) to the control media at a final
concentration twice that of α-MEM. Cells were also incubated with 200 μM hydralazine
hydrochloride (Sigma Aldrich, St. Louis, MO) in 1% FBS medium for 24h.
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Real-Time PCR
Total RNA was isolated and purified from Caco-2 Bbe cells using TRIzol
(Invitrogen, Carlsbad, CA) extraction and the RNeasy Mini Kit (QIAGEN, Valencia, CA).
Total RNA was reverse transcribed to cDNA using the iScriptTM cDNA Synthesis Kit
(Bio-Rad, Hercules, CA) and the reverse transcription reaction performed on a C1000TM
Touch Thermal Cycler System (Bio-Rad, Hercules, CA) using the following protocol:
25°C for 5 min, 42°C for 30 min, and 85°C for 5 min. Real-time PCR analyses were
performed using a Taqman® Gene Expression Assay for DMT1 (Hs00895682_m1,
Applied Biosystems, Foster City, CA) and iTaqTM Universal Probes Supermix (Bio-Rad,
Hercules, CA). β-actin was used as an endogenous reference (Hs01060665_g1,
Applied Biosystems, Foster City, CA). To ensure that the effect of amino acids on
DMT1 expression was not due to a generalized effect of adding amino acids, the level
of heme carrier protein 1/proton-coupled folate transporter (HCP1/PCFT) transcript
expression was also quantified using a Taqman® Gene Expression Assay for HCP1
(Hs00560565_m1). PCR reactions were run in an iQ2 Optical System (Bio-Rad,
Hercules, CA) using the following protocol: 95°C for 10 min, followed by 40 cycles at
95°C for 20 sec and 60°C for 1 min. Relative quantification of target genes was
calculated using the comparative CT method.

Western Blotting
Caco-2 Bbe cells were seeded into 60 mm dishes at a density of 8 x 105
cells/dish and studied 18-22 days post confluent. To examine the direct effect of amino
acids on DMT1 protein expression, cells were incubated for 24 hours with the same
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solutions used in the real-time PCR studies (see above). After the 24h treatment
period, RIPA lysis buffer (1% Triton-X 100, 1% Na deoxycholate, 0.1% SDS, 158 mM
NaCl, 5 mM EDTA, 10 mM Tris pH 7.2) containing protease inhibitors (Roche
Diagnostics Corporation, Indianapolis, IN) was added and cells removed using a plastic
cell scraper. The cell/lysis buffer mixture was placed on ice for 10 min, and
subsequently centrifuged at 4°C for 15 min at maximum speed. The remaining pellet
was discarded and the supernatant collected and assayed for total protein content using
a BCATM protein assay (Thermo Scientific, Rockford, IL). SDS-PAGE gel
electrophoresis was performed using standard western blot procedures. A rabbit
polyclonal antibody to DMT1 that detects a band of approximately 64 kDa (sc-30120,
Santa Cruz Biotechnology, Inc., Santa Cruz, CA) was used. β-actin was used as a
loading control (sc-47778, Santa Cruz Biotechnology, Inc., Santa Cruz, CA) and mouse
kidney lysate was used as a positive control for the DMT1 antibody.

Cloning Procedures
A 616-bp 5’ flanking region of the DMT-1A exon was amplified from human genomic
DNA and subcloned into the pLVX-MetLuc lentiviral vector by BamHI and EcoRI
digestion after PCR (Clontech, Mountainview, CA). The promoter construct was
confirmed by sequencing.

Lentiviral Infection and Luciferase Assays
Lentiviral preparations were generated according to the manufacturer’s
instructions. Briefly, 80-90% confluent Lenti-X 293T packaging cells were transfected
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with the DMT1 promoter construct using the Lenti-X HTX Packaging System (Clontech,
Mountainview, CA). Forty-eight hours after transfection, lentiviral supernatants were
harvested and virus production was verified using Lenti-X GoStixTM (Clontech,
Mountainview, CA). Twelve to eighteen hours prior to lentiviral transduction, Caco-2
Bbe cells were plated in 12-well plates at a density of 1 x 105 cells/well in their complete
growth medium. The next day, Caco-2 cells were transduced with viral supernatant for
16 hours using Polybrene as per the manufacturer’s protocol. Infected cells were
incubated for an additional 48 hours in complete growth medium before the initiation of
antibiotic selection using 8 μg/mL puromycin dihydrochloride (Gibco, Carlsbad, CA).
Stable transfectants were routinely passaged using Trypsin/0.5% EDTA when 80-90%
confluent. Cells were cultured in normal growth media (described above) containing 8
μg/mL puromycin dihydrochloride and media was changed every 2-3 days.
For the luciferase assays, Caco-2 Bbe cells stably transduced with the DMT1ppLVX-MetLuc construct were seeded into 12-well plates at a density of 1 x 106 cells/well
and studied at 18-22 days post confluent. To examine a direct effect of amino acids on
DMT1 promoter activity, cells were incubated for 6 and 24 hours with the same
solutions used in the real-time PCR and Western blotting studies described above.
Following treatment, conditioned media was collected and Metridia luciferase assays
performed using the Lenti-XTM Ready-To-GlowTM Secreted Luciferase Reporter Assay
as per the manufacturer’s instructions (Clontech, Mountainview, CA).
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Statistical Analyses
Statistical analyses were performed using GraphPad Prism version 6.0a
(GraphPad Software Inc., La Jolla, CA). A student’s t test was used to analyze
experiments conducted on only two groups. For all statistical analyses, differences with
a P value < 0.05 were considered significant. Data are shown as means ± standard
error of the mean (SEM).

Results
Amino acids increase DMT1 transcript expression
Previous data from our laboratory showed that increasing dietary protein
augments duodenal DMT1 mRNA expression in rats. To investigate whether this effect
of protein/amino acids on DMT1 transcript expression is direct, Caco-2 Bbe cells were
utilized. The effect of amino acids on DMT1 expression was explored by exposing
Caco-2 cell monolayers to control media or amino acid-supplemented media for 6 and
24h and evaluating DMT1 mRNA expression by real-time PCR. Cell viability analysis
demonstrated that amino acid supplementation had no deleterious effect on cell viability
compared to the control treatment (78.1% viable and 77.6% viable, respectively).
As shown in Figure 1A, consistent with previous reports by others, incubation of
Caco-2 cells with 200 μM hydralazine hydrochloride for 24h significantly increased
DMT1 mRNA expression by ~3.5-fold compared to regular growth media (P = 0.042).45
Incubation of post confluent Caco-2 cells with amino acid-supplemented media for 6h
had no effect on DMT1 transcript expression (Figure 1B; P = 0.68). However, when
Caco-2 cells were supplemented with amino acids for 24h, real-time PCR revealed a

80

significant 1.8-fold induction in DMT1 expression compared to control cells (Figure 1C;
P = 0.0039). Importantly, amino acid supplementation had no stimulatory effect on
HCP1 transcript expression (Figure 1D), suggesting that the effect of amino acids on
DMT1 was specific.

No detectable effect of hydralazine or amino acids on DMT1 protein expression
We next determined if the increase in DMT1 transcript expression resulted in a
detectable change in DMT1 protein levels. Despite a significant effect of hydralazine
hydrochloride on DMT1 mRNA expression, there was no significant effect of hydralazine
on DMT1 protein expression by Western (Figure 2A and 2B). Likewise, amino acid
supplementation had no apparent effect on DMT1 protein expression (Figures 2C and
2D).

Amino acids augment DMT1 promoter activity
To test whether the observed increase in DMT1 mRNA expression in response to
amino acid supplementation was due to enhanced DMT1 promoter activity, luciferase
assays were conducted in post confluent Caco-2 cells stably expressing DMT1
promoter-driven Metridia luciferase. As shown in Figure 3A, 24-h treatment of Caco-2
cells with 200 μM hydralazine hydrochloride significantly induced the activity of the
DMT1 promoter compared to both control (non-infected) and untreated cells (P < 0.01).
This is in agreement with other reports and indicates that the DMT1 promoter is active
and responsive to known transcriptional activators.45 DMT1 promoter activity was
unaffected by 6-h amino acid treatment (data not shown), which is consistent with the
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real-time PCR findings at this time point. Interestingly, 24-h amino acid treatment
significantly augmented DMT1 promoter activity by 1.6-fold compared to control cells
(Figure 3B; P < 0.0001).

Discussion
Dietary protein has long been known to affect intestinal iron absorption, but the
mechanism has generally been thought to be an effect on iron bioavailability in the GI
tract. We previously demonstrated that a high protein diet increases duodenal iron
uptake in vivo, due in part to augmented DMT1 transcript expression. In this study,
amino acid treatment of Caco-2 cells significantly enhanced DMT1 transcript expression
and the activity of the DMT1 promoter. However, the amino acid-induced increase in
DMT1 transcript expression was not associated with a detectable change in DMT1
protein expression.
Together, these data suggest that the enhancement in DMT1 expression we
observed in vivo in response to increasing dietary protein may be due at least in part to
a direct effect of amino acids on DMT1 transcription. To our knowledge, this study is
the first to identify a direct nutrient effect on DMT1 mRNA expression and DMT1
transcriptional activity. While cellular iron status is known to affect DMT1 mRNA
stability through the IRE/IRP system, little is known about transcriptional regulation of
DMT1. However, recently hypoxia has been shown to augment DMT1 transcription via
HIF-2α binding to hypoxia-responsive elements (HREs) in the DMT1 promoter.45 The
mechanism(s) by which amino acids affect DMT1 transcription was not examined in this
study, however it is possible that amino acid response elements (AAREs) are involved
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in the regulation of DMT1 transcription by amino acid supplementation. There are two
examples of amino acid deprivation regulating gene transcription. Leucine deprivation
is known to transcriptionally activate the stress response gene CHOP via an AARE in
the 5’ regulatory region of the gene.111 A second example is the enzyme asparagine
synthetase, which is transcriptionally activated by amino acid deficiency. As is the case
for the CHOP gene, an AARE mediates this amino acid effect on asparagine
synthetase.112 Although amino acid deprivation has been shown to regulate gene
transcription, we are unaware of any data demonstrating the ability of supplemental
amino acids to transcriptionally activate genes. It will be of interest to define the
region(s) of the DMT1 promoter responsive to amino acid supplementation by
conducting deletional and mutational analyses of the promoter region. Examining the
DMT1 promoter sequence for the presence of consensus AAREs would help in
evaluating whether AAREs are involved in the regulation of DMT1 transcription by
amino acids.
Our inability to detect a significant effect of amino acids on DMT1 protein
expression should not be surprising, since the induction in DMT1 transcript expression
that was observed was fairly modest (1.8 fold). Nutrient effects on gene expression are
typically small, therefore Western blotting may not be sensitive enough to detect an
effect of amino acids on DMT1 protein expression if one exists. The relative
insensitivity of our Western blotting methodology is further supported by the fact that
although hydralazine hydrochloride treatment significantly augmented DMT1 transcript
levels by 350%, it had no apparent effect on DMT1 protein expression (Figure 2A and
2B).
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In summary, amino acids augment DMT1 mRNA expression by directly
increasing DMT1 promoter activity in vitro. The molecular mechanisms underlying this
effect are not yet known.
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1C.

1D.

Figure 1. A. DMT1 mRNA expression in response to 24-h treatment with 200 μM
hydralazine hydrochloride. B. DMT1 mRNA expression in response to 6-h treatment with
control media and media supplemented with amino acids. C. DMT1 mRNA expression in
response to 24-h treatment with control media and media supplemented with amino acids.
D. HCP1 mRNA expression in response to 24-h treatment with control media and media
supplemented with amino acids. *P < 0.05, **P < 0.01
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Figure 2. DMT1 protein expression in Caco-2 cells. A. DMT1 expression by Western blot in
Caco-2 cells exposed to growth media and 200 μM hydralazine hydrochloride for 24 h. B.
Relative expression of DMT1 in A., normalized to β-actin. C. DMT1 expression by Western blot
in Caco-2 cells exposed to control media and 2x amino acids (2x AA) for 24 h. D. Relative
expression of DMT1 in C., normalized to β-actin.
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Figure 4. DMT1 promoter activity in response to A) 200 μM hydralazine hydrochloride for 6h and
24h and B) amino acid supplemented media for 24 h. *P < 0.01, **P < 0.0001
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Chapter 7
Increasing Dietary Protein Suppresses Hepatic Hepcidin Expression
In Vivo

Introduction
One of the most important systemic hormones regulating iron absorption is
hepcidin, a 25-amino acid peptide hormone produced and secreted by the liver in
response to iron overload and inflammation.91 Hepcidin functions by binding to and
causing the internalization and degradation of FPN1 on the basolateral membrane of
duodenal enterocytes.28 The consequence is a rise in intracellular iron, which in turn
suppresses the expression of DMT1, Dcytb, and ultimately intestinal iron absorption.
Hepcidin may also directly affect the expression of DMT1 and Dcytb in enterocytes,
since hepcidin treatment was recently found to induce a significant reduction in DMT1
protein expression in Caco-2 cells.113 The exact mechanism by which hepcidin senses
iron has not been fully elucidated but it is well accepted that the bone morphogenic
protein (BMP) signaling pathway is intimately involved in this process. In iron replete
conditions, BMP6 binds to the BMP cell surface receptor in conjunction with the BMP
co-receptor hemojuvelin (HJV), which initiates an intracellular signaling cascade
involving the phosphorylation of SMAD1/5/8 and translocation of a SMAD1/5/8-SMAD4
complex to the nucleus, where it binds to enhancers in the hepcidin promoter, activating
transcription.92 Induction of hepcidin transcription also occurs through the binding of
holotransferrin to TfR2 in a complex with the hemochromatosis protein, HFE.42 The
intracellular signaling pathways involved in this process have not been clarified but it is
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thought that there is crosstalk with BMP/SMAD signaling. Holotransferrin binding to
TfR2 on the cell surface of hepatocytes also causes stabilization of TfR2, further
enhancing the interaction with HFE and in turn, hepcidin transcription. During iron
depletion however, hepcidin transcription is suppressed through 3 separate
mechanisms in the hepatocyte. First, the expression of TfR1 on the cell membrane of
hepatocytes increases, causing it to sequester HFE and inhibit HFE binding to TfR2.
Additionally, a recently identified hepatocyte membrane serine protease, matriptase-2
(gene name TMPRSS6), has been shown to cleave the membrane-bound BMP coreceptor HJV, thus preventing the binding of BMP6 to its BMP-HJV receptor complex.114
Finally, iron deficiency increases the release of the soluble form of the BMP co-receptor
HJV, which then sequesters BMP6 extracellularly and prevents its interaction with
membrane-bound HJV.115 Thus, several mechanisms are in place to control hepatic
hepcidin expression in response to changes in iron status and availability.
Recent data from our group showed that increasing dietary protein from a
medium to a high level in rats significantly augments intestinal iron absorption and
expression of the duodenal iron import proteins, DMT1 and Dcytb, but not the iron
export protein FPN. Since hepcidin is a major factor in the regulation of iron absorption,
and reduced hepcidin expression has been shown to be associated with significant
increases in DMT1 and Dcytb transcript expression, we thought it plausible that hepatic
hepcidin expression may also be altered in our model. Therefore, the purpose of this
study was to determine if increasing dietary protein affects hepatic hepcidin expression
in vivo in rats and in vitro in primary rat hepatocytes. Given that there have been no
reports indicating that dietary protein can influence hepcidin production in the liver, it
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was hypothesized that dietary protein would have no effect on hepatic hepcidin
expression.

Materials and Methods
Experimental animals and diets
The diet study protocol and experimental diets used in this work have been
previously described.108 Briefly, 250 to 300 g adult female Sprague Dawley rats (n = 28)
were purchased from Charles River Laboratories, Inc. (Wilmington, MA). Animals were
housed in the Yale Animal Resource Center and cared for in accordance with
institutional animal care use policies. All experiments were approved by the Yale and
University of Connecticut Institutional Animal Care and Use Committees. On arrival,
rats were placed on standard diet 2018, Teklad Global 18% Protein Rodent Diet (Harlan
Teklad, Inc., Madison, WI), for a minimum of 2 wk to allow for acclimation. For all
studies, experimental diets were obtained from Harlan Teklad and were nutritionally
complete and isocaloric (Table 1). The 20% protein diet was used as a normal or
moderate protein diet and was representative of the standard rat diet 2018, which
contains 24% protein. The 40% protein diet was used as the high protein diet. The
20% protein diet was made isocaloric to the 40% protein diet by the addition of
cornstarch. Lipid from corn oil was held constant in both diets at 14-15% of total kcal.

Real-time PCR
Real-time PCR was performed using RNA isolated from the livers of rats
consuming different levels of dietary protein. Twenty-eight rats were randomized to

92

either a 20 or 40% protein diet for 12 days. On d 12 of the diets, rats were
anesthetized, the abdominal cavity was opened, and sections of the liver removed and
snap frozen in liquid N before storage at -70°C. For total RNA extraction, livers were
ground in liquid N using a mortar and pestle and extracted with TRIzol (Invitrogen,
Carlsbad, CA), followed by purification using the RNeasy Mini Kit (QIAGEN, Valencia,
CA). Total RNA was reverse transcribed to cDNA using the iScriptTM cDNA Synthesis
Kit (Bio-Rad, Hercules, CA) and the reverse transcription reaction performed on a
C1000TM Touch Thermal Cycler System (Bio-Rad, Hercules, CA) using the following
protocol: 25°C for 5 min, 42°C for 30 min, and 85°C for 5 min. Real-time PCR analyses
were performed using Taqman® Gene Expression Assays for the following targets:
hepcidin (Rn00584987_m1), BMP6 (Rn00432095_m1), interleukin-6 (IL-6)
(Rn01410330_m1), TfR1 (Rn01474701_m1), and TMPRSS6 (Rn01504798_m1)
(Applied Biosystems, Foster City, CA) and iTaqTM Universal Probes Supermix (Bio-Rad,
Hercules, CA). Hypoxanthine phosphoribosyltransferase 1 (Hprt1) was used as an
endogenous reference (Rn01527840_m1, Applied Biosystems, Foster City, CA). PCR
reactions were run in an iQ2 Optical System (Bio-Rad, Hercules, CA) using the
following protocol: 95°C for 10 min, followed by 40 cycles at 95°C for 20 sec and 60°C
for 1 min. Relative quantification of target genes was calculated using the comparative
CT method.

Primary rat hepatocyte culture
Freshly isolated primary rat hepatocytes from Sprague Dawley rats were
purchased from Invitrogen (Carlsbad, CA). Upon receipt, hepatocytes were
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immediately seeded into collagen-coated 12-well plates at a density of 1 x 105 cells/well.
To first determine if hepcidin transcript expression could be efficiently altered in this
model, hepatocytes were treated for 6 and 24 h with heparin sulfate (400 μg/mL) as
described by others.116 To determine whether amino acids directly affect hepcidin
expression, hepatocytes were treated with 2x amino acid media, or control hepatocyte
maintenance media (William’s E Medium, 0.05% penicillin/streptomycin, 1% ITS+, 1%
L-glutamine, 15 mM HEPES, and 0.1 μM dexamethasone) for 6 and 24 h. 2x amino
acid media was prepared by adding a mixture of essential and non-essential amino
acids to hepatocyte maintenance media, such that the final concentration of amino
acids was twice that of the maintenance media with no added amino acids. After
treatment for the indicated times, RNA was extracted, cDNA synthesized, and QPCR
performed as described above.

Statistical Analyses
Statistical analyses were performed using GraphPad Prism version 6.0a
(GraphPad Software Inc., La Jolla, CA). A student’s t test was used to analyze
experiments conducted on only two groups. One-way ANOVA was used to analyze
experiments conducted on 3 groups. For all statistical analyses, differences with a P
value < 0.05 were considered significant. Data are shown as means ± SEM.
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Results
A high protein diet suppresses hepatic hepcidin expression in vivo
As shown in Figure 1A, animals consuming the 40% protein diet exhibited
significantly reduced hepatic hepcidin mRNA levels compared to those consuming the
20% protein diet. Specifically, the high protein diet suppressed hepcidin transcript
expression by 44% compared to the medium protein diet (P = 0.0006).
To evaluate whether any genes known to be involved in the regulation of
hepcidin transcription were altered in response to increasing dietary protein, the mRNA
levels of BMP6, TMPRSS6, and TfR1 were evaluated using real-time PCR.
Interestingly, BMP6 transcript expression was significantly reduced in response to the
40% protein diet compared to the 20% protein diet, such that animals consuming the
40% diet exhibited 20% lower BMP6 levels than those on the 20% protein diet (Figure
1B, P = 0.0193). Additionally, TfR1 transcript levels were significantly different between
the two diet groups. In particular, TfR1 mRNA expression was significantly greater in
the 40% group compared to the 20% group, with a fold difference of 1.5 (Figure 1C, P =
0.0087). However, dietary protein had no consistent effect on TMPRSS6 mRNA levels
(Figure 1D).
Since inflammation is also known to induce hepcidin transcription, real-time PCR
was performed to determine whether increasing dietary protein affects hepatic IL-6
expression. As shown in Figure 2, there was no significant difference in IL-6 mRNA
expression between the two diet groups, suggesting that there was no change in
inflammatory status in response to changes in dietary protein.
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Amino acids have no impact on hepatic hepcidin expression in primary rat
hepatocytes
To test the hypothesis that dietary protein/amino acids directly affect hepcidin
expression, primary rat hepatocytes were utilized. First, to determine whether hepcidin
could be efficiently altered in this model, hepatocytes were incubated with 10 ng/mL IL-6
(to induce hepcidin) and 400 μg/mL heparin sulfate (to suppress hepcidin) for 6 and
24h. Neither heparin sulfate nor IL-6 treatment for 6h affected hepcidin expression
(data not shown). However, 24-h incubation with IL-6 augmented hepcidin expression
by 5.2-fold, while 400 μg/mL heparin sulfate modestly suppressed hepcidin mRNA
expression by 34% compared to cells incubated with control media (Figure 3A).
Next the effect of amino acids on hepcidin expression was examined. As shown
in Figure 3B, 24-h treatment with 2x amino acids added to hepatocyte maintenance
media enhanced hepcidin transcript levels by ~1.6-fold compared to cells incubated with
hepatocyte maintenance media, however this difference was not statistically significant
(P = 0.152).

Discussion
In the present study, we found that acute changes in dietary protein significantly
affects hepatic hepcidin expression as well as the expression of genes known to be
involved in the regulation of hepcidin transcription in the liver. Specifically, rats
consuming a high protein diet (40%) for 12 d exhibited a ~50% suppression in hepatic
hepcidin transcript expression compared to rats fed a medium protein diet (20%). This
substantial reduction in hepcidin expression with increasing protein intake was
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associated with significant changes in both BMP6 and TfR1 expression in the liver.
Increasing dietary protein suppressed BMP6 mRNA levels by 20%, whereas TfR1
mRNA was augmented by 50%. However, there was no observed difference in
TMPRSS6 transcript expression with increasing dietary protein.
These findings suggest that suppression of hepatic hepcidin expression may be
partially responsible for the concomitant increase in intestinal iron absorption and
expression of duodenal iron transporters that we observed with increasing dietary
protein. To our knowledge, there are no other reports of dietary protein affecting
hepcidin expression in the liver. The only nutrient known to impact hepcidin production
is iron. The mechanism by which dietary protein represses hepcidin expression is not
known, but the in vitro data presented above imply that amino acids do not directly
reduce hepcidin transcript expression. In fact, in our in vitro primary rat hepatocyte
model, additional amino acids augmented hepcidin mRNA levels, which is in stark
contrast to our in vivo results. It is unclear whether this discrepancy is a reflection of a
poor in vitro model or an indication that other systemic factors not present in the in vitro
setting are involved in the regulation of hepcidin expression by dietary protein. In
support of the latter are findings from Sasaki et al., which show that sufficient dietary
protein is important for erythropoiesis and that variations in dietary protein levels affect
circulating erythropoietin (EPO) concentrations.117 Interestingly, this report
demonstrated that EPO concentrations in rat serum increased as protein content of the
diet increased, such that EPO rose from an undetectable level (< 4 mU/mL) with protein
deprivation to 35 mU/mL with a 20% casein diet. The authors suggest that certain
amino acids may function as a signal to the kidney to stimulate EPO production,
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including secretion of already synthesized EPO into the bloodstream. This is relevant to
our findings since EPO and erythropoietic drive have been shown to negatively regulate
hepcidin expression.118 Thus, it is plausible that increasing protein in the diet augments
erythropoiesis and EPO production in the kidney, which in turn suppresses hepcidin
transcription in the liver. Unfortunately, kidney tissue was not collected in our study
therefore this possibility could not be fully explored.
It is intriguing that animals on the high protein diet exhibited significantly reduced
BMP6 and enhanced TfR1 transcript levels compared to those on the medium protein
diet. These changes most likely contributed to the difference observed in hepcidin
expression, since BMP6 is a known inducer of hepcidin, and increased TfR1 expression
inhibits hepcidin production. The mechanism by which increasing dietary protein affects
the hepatic expression of these genes is currently unknown.
In summary, these data clearly demonstrate that increasing dietary protein in the
short-term significantly reduces hepatic hepcidin mRNA expression and that this effect
may be attributed at least in part to reduced expression of BMP6 and enhanced
expression of TfR1 in the liver. The underlying mechanism responsible for these effects
is not yet known but may involve the stimulation of erythropoiesis and circulating EPO
levels by protein.

98

For macronutrients % refers to % of total kcal.
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1A.

1B.
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1C.

1D.

Figure 1. Transcript expression of A) hepcidin, B) BMP6, C) TfR1, and D) TMPRSS6 in the livers of
female rats consuming medium (20%) and high (40%) protein diets for 12 d. (N = 14 per group). *P
< 0.05, ** P < 0.001.
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Figure 2. Hepatic IL-6 mRNA expression in female rats consuming medium (20%) and high
(40%) protein diets for 12 d. (N = 14 per group).
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A.

B.

Figure 3. Hepcidin mRNA expression in primary rat hepatocytes treated for 24 h with
maintenance media, 10 ng/mL IL-6, and 400 μg/mL heparin sulfate. B. Hepcidin mRNA
expression in primary rat hepatocytes treated for 24 h with maintenance media and 2x amino
acids in maintenance media. *P < 0.05 compared to heparin treatment by one-way ANOVA and
post hoc analysis by Tukey’s multiple comparisons test.
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Chapter 8
Conclusions and Future Study Directions

Dietary protein has been shown to affect intestinal iron absorption for decades.
The majority of studies investigating this relationship have focused on the effect of
protein on iron bioavailability and demonstrate that whether protein has an enhancing or
inhibitory effect depends on the protein source. Data from our laboratory provide
evidence that increasing dietary protein significantly enhances intestinal iron absorption,
which may potentially improve iron status. This protein-induced increase in iron
absorption is due at least in part to augmented expression of duodenal iron
transporters, as demonstrated by whole genome profiling. To further explore the
mechanism by which a high protein diet enhances intestinal iron absorption and the
expression of DMT1, we used Caco-2 cells as a model of the intestinal epithelium.
Findings from these in vitro experiments indicate that amino acids directly increase
DMT1 transcript expression and the activity of the DMT1 promoter. These data are the
first to demonstrate a direct effect of protein/amino acids on the expression of genes
involved in iron absorption. Follow-up experiments to this work would include deletional
and mutational analyses of the DMT1 promoter, which would indicate the region of the
promoter that is responsive to amino acid supplementation. Additionally, it would be
important to evaluate whether certain amino acids or functional groups of amino acids
are responsible for the effect on DMT1 expression we observed in this study.
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We also found that acutely increasing protein in the diet of rats resulted in
suppressed hepatic hepcidin expression. This was associated with alterations in the
expression levels of BMP6 and TfR, which are known regulators of hepcidin
transcription. It is unclear how dietary protein exerts these effects. It is also possible
that EPO production and/or secretion by the kidney is stimulated by protein and that this
plays a role in dietary protein-induced suppression of hepcidin. Dietary protein has
been shown to be important for adequate erythropoiesis and EPO production and in
turn, erythropoietic drive reduces hepcidin production and improves intestinal iron
absorption.119 To determine whether the suppressive effect of dietary protein on
hepcidin expression is due in part to augmented EPO expression, it would first be
important to measure circulating EPO levels in our animal model. Alternatively, a
mouse model of EPO deficiency could be utilized. Deletion of functional EPO is
embryonic lethal. However, Zeigler et al. created an inducible EPO knockout mouse
using tamoxifen-inducible Cre.120 To examine whether EPO is important for the
suppression of hepcidin in response to increasing dietary protein, EPO knockout mice
would be randomized to consume diets containing various levels of dietary protein for
~1 wk. Following the dietary intervention period, hepatic hepcidin expression and
intestinal iron absorption would be measured. The hypothesis for this study would be
that intestinal iron absorption and hepatic hepcidin expression in knockout animals
consuming a high protein diet would equal that of animals consuming low and medium
protein diets.
An alternative study, which would re-evaluate whether dietary protein/amino
acids directly affect hepatic hepcidin expression, would involve in vivo portal vein
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perfusion. It is possible that our in vitro rat hepatocyte model is not physiologically
relevant to the in vivo situation. Blood leaving the gut via the hepatic portal vein first
passes though the liver, and it is estimated that 20-50% of the free amino acids entering
the blood do not get past the liver.121 Therefore it is plausible that amino acids directly
affect hepatic hepcidin expression. In vivo perfusion of the rat portal vein with amino
acids may represent a more appropriate technique for evaluating the effect of
postprandial changes in amino acid concentrations on the liver and hepatic hepcidin
expression.
Finally, we did not observe a significant effect of acutely increasing dietary
protein on iron status in postmenopausal women. However, this is not entirely
surprising since iron status of postmenopausal women is generally better than that of
their younger counterparts. Additionally, 10 days of a high protein diet may not be a
sufficient length of time to observe appreciable changes in iron status. Therefore,
longer duration studies should be conducted in individuals at higher risk of iron
deficiency to more appropriately address this important question. Changes in intestinal
iron absorption in response to increasing dietary protein could also be evaluated in
these subjects using stable iron isotopes. These studies would provide insight into
whether our observations in rats are relevant to humans.
In conclusion, the results of the studies conducted for this dissertation suggest
that dietary protein enhances intestinal iron absorption, which is due at least in part to a
direct effect of amino acids on duodenal DMT1 transcription and an inhibitory effect of
dietary protein on hepatic hepcidin expression.
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Chapter 9
Significance

These studies have important public health implications. Currently, it is
estimated that iron deficiency affects 4-5 billion people globally, which represents 6070% of the world’s population.122 Poor iron status can have devastating and longlasting effects including cognitive deficits and reduced work capacity. Several reports,
including ours, suggest that dietary protein improves intestinal iron absorption and as a
result, may have beneficial effects on iron status. In particular, it is thought that a
certain amount of dietary protein is necessary for optimal iron absorption. For example,
Klavins et al. concluded that 15-18% protein is necessary to meet normal needs for iron
absorption, and that when smaller amounts of protein are consumed, absorption of iron
is impaired.75 Similarly, Kruchakova showed that iron assimilation is greater in
experimental animals fed diets containing 20 and 40% casein than in animals
consuming 5% casein.90 Aside from effects on intestinal iron absorption and iron status,
greater consumption of dietary protein has been shown to have additional health
benefits including promoting weight loss via increasing satiety. Finally, previous work
from our group has demonstrated that increasing dietary protein enhances intestinal
calcium absorption, which may have favorable effects on skeletal health and the
preservation of bone mass.98,123,124
In general, the majority of healthy Americans are able to meet or exceed dietary
protein recommendations. In 2008, Fulgoni reported usual protein intakes using data
from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and
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showed that average intake of protein (in % of total kcal) is 14% for females and 14.6%
for males under 51 y.125 The current recommendation is that individuals consume 1035% of their total kcal from protein, however, it was found that virtually none of the
population approaches 35%.125,126 In fact, estimated protein intakes described above
indicate that most individuals consume less than half of the upper acceptable
macronutrient distribution range (AMDR) of 35%. Furthermore, almost 10% of
adolescent females consume less protein than the estimated average requirement
(EAR). Our data suggest that increasing protein intake may have beneficial effects on
iron absorption and iron status in certain individuals in our population, such as
adolescent females, whose protein intake is low and the risk for iron deficiency higher.
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